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ABSTRACT 
 
Directed Evolution of Phosphotriesterase for Detoxification of the  
Nerve Agent VX. (August 2006) 
Eman Mohamed Ghanem, B.S., Ain Shams University; M.S., Eastern Illinois University 
Chair of Advisory Committee: Dr. Frank M. Raushel 
 
 
 
 Phosphotriesterase (PTE) isolated from the soil bacterium Flavobacterium sp. is 
a member of the amidohydrolase superfamily.  PTE catalyzes the hydrolysis of a broad 
spectrum of organophosphate triesters including the insecticide paraoxon, and the 
chemical warfare agents; GF, sarin, and soman.  In addition, PTE has been shown to 
catalytically hydrolyze the lethal nerve agent, VX.  However, the rate of VX hydrolysis 
is significantly slower.  PTE was subjected to directed evolution studies to identify 
variants with enhanced activity towards VX hydrolysis.  First generation libraries 
targeted amino acid residues in the substrate binding site.  The H254A mutation 
displayed a 4-fold enhancement in kcat and a 2-fold enhancement in kcat/Km over wild 
type PTE.  The double mutant H254Q/H257F was isolated from the second generation 
libraries and displayed a 10-fold enhancement in kcat and a 3-fold enhancement in 
kcat/Km.  In addition, H254Q/H257F displayed a 9-fold enhancement in kcat/Km for the 
hydrolysis of the VX analog, demeton-S.   
 An in vivo selection approach utilizing organophosphate triesters as the sole 
phosphorus source is discussed.  The selection is based on co-expressing PTE with the 
phosphodiesterase (GpdQ) from E. aerogenes.  Substrate specificity of GpdQ was 
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investigated using a small library of structurally diverse organophosphate diesters and 
phosphonate monoesters.  Results obtained from the in vivo growth assays showed that 
GpdQ enabled E. coli to utilize various organophosphate diesters and phosphonate 
monoesters as the sole phosphorus source.  Cells co-expressing PTE and GpdQ were 
tested for their ability to utilize two different organophosphate triesters as the sole 
phosphorus source.  The results from this experiment indicate that the growth rate is 
limited by the phosphotriesterase activity. 
 Protein translocation to the periplasm was proven advantageous for in vivo 
selection since it overcomes the limitation of intercellular delivery of the substrate of 
interest. Translocation of PTE to the periplasmic space of E. coli was examined.  Two 
signal peptides were tested; the native leader peptide from Flavobacterium sp. and the 
signal sequence of alkaline phosphatase.  The results obtained from cellular fractionation 
indicated that neither signal peptides were able to translocate PTE to the periplasm and 
that the protein remained in the cytoplasm.     
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CHAPTER I 
INTRODUCTION 
 
Organophosphate triesters have been employed in the agricultural industry as 
pesticides and insecticides for several decades.  Approximately 60 million pounds of 
various organophosphates are applied annually to agriculture crops in the US.  The most 
toxic organophosphorus compounds known are the lethal nerve agents, tabun (GA), sarin 
(GB), soman (GD), and VX as shown in Scheme 1.1.  The toxicity of these compounds 
is due primarily to the practically irreversible inhibition of acetylcholine esterase 
(AchE), the enzyme responsible for hydrolysis of the neurotransmitter acetylcholine 
(Ecobichon, 2001).  Enzymes that are capable of hydrolyzing and detoxifying such 
agents are of significant utility.  
 
 
 
 
 
Scheme 1.1. Structure of organophosphate nerve agents 
 
 
 
This dissertation follows the style of Toxicology and Applied Pharmacology. 
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Several organophosphate degrading enzymes have been isolated and 
characterized.  The best characterized among them is the phosphotriesterase (PTE) that 
was initially isolated from the soil bacterium Flavobacterium sp. strain ATCC 27551 
identified in Philippines (Raushel and Holden, 2000).  The opd (organophosphate 
degrading) gene encoding the active hydrolase was located on an extrachromosomal 
plasmid.  
The gene for the bacterial phosphotriesterase was subcloned into several 
expression systems, including Escherichia coli (Dumas et al., 1989), insect cells (Dumas 
et al., 1990a) and in vitro compartmentalization (Griffiths and Tawfik, 2003).  The 
natural substrate for PTE remains unknown.  However, the purified enzyme is capable of 
hydrolyzing the insecticide paraoxon at a rate that approaches the diffusion-controlled 
limit as presented in Scheme 2.2.  The turnover number of the zinc-substituted PTE for 
paraoxon hydrolysis is 2100 s-1, while the corresponding value for kcat/Km is 4 x 107     
M-1s-1.  Since the synthesis of paraoxon was first reported in 1950 (Schrader, 1950), it is 
remarkable that PTE could have evolved to such a catalytic efficiency over a relatively 
short period of time.  PTE also possesses the ability to catalyze the hydrolysis of a wide 
spectrum of organophosphate insecticides including parathion, methyl-parathion, 
fensulfothion, among others (Dumas et al., 1989).  In addition, PTE is capable of 
hydrolyzing the nerve agents sarin, soman, and VX, but the catalytic efficiency for these 
substrates are significantly lower than the less toxic insecticides (Dumas et al., 1990b; 
Kolakowski et al., 1997).  
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Scheme 1.2. Hydrolysis of paraoxon by PTE. 
 
Three Dimensional Structure of Phosphotriesterase 
 Phosphotriesterase is a member of the amidohydrolase superfamily (Holm and 
Sander, 1997), which also includes urease (Jabri et al., 1995) and dihydroorotase 
(Thoden et al., 2001) among others.   Members of this superfamily utilize one or two 
divalent metal ions to activate a hydrolytic water molecule for a nucleophilic attack at 
tetrahedral phosphorus or trigonal carbon centers.  PTE is a homodimeric metalloprotein 
with a molecular weight of ~36 kDa/monomer (Benning et al., 1994).  A high resolution 
X-ray structure has been solved for the bacterial PTE (Benning et al., 2001). The active 
site of the native enzyme contains two zinc ions per monomer.  Incubation of PTE with 
various metal chelators such as EDTA and 1,10-phenanthroline renders the enzyme 
inactive (Omburo et al., 1992).  The enzyme retains catalytic activity when the native 
Zn2+ is replaced by Co2+, Cd2+, Ni2+, or Mn2+ (Omburo et al., 1992). 
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Like other members of the amidohydrolase superfamily, PTE adopts a TIM-
barrel (αβ)8-fold where the binuclear metal center is located at the C-terminal end of the 
β-barrel (Figure 1.1).  The more buried metal ion in the active site, also known as the α-
metal, is ligated to His-55, His-57, and Asp-301.  The more solvent exposed metal ion 
(β-metal) is coordinated by His-201, His-230, and a water molecule.  The two metal ions 
are bridged by the carboxylated Lys-169 and a water/hydroxide molecule, which is the 
apparent nucleophilic species during the hydrolysis reaction (Figure 1.2).  
The X-ray structure of phosphotriesterase bound with the prochiral substrate 
analog, diethyl 4-methylbenzylphosphonate, revealed the presence of three subsites for 
substrate binding: the small, large and leaving group pockets accommodate the three 
substituents attached to the phosphorus center (Vanhooke et al., 1996).  The large 
subsite contains residues His-254, His-257, Leu-271, and Met-317.  The small binding 
pocket is defined by the residues, Gly-60, Leu-303, Ser-308, and Ile-106.  The 
hydrophobic leaving group pocket contains the residues Phe-306, Phe-132, Trp-131, and 
Tyr-309 (Figure 1.3).  It has been shown that the side chains of these twelve residues 
dictate the substrate and stereo-selectivity of PTE.  
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Figure 1.1. The crystal structure of phosphotriesterase featuring a TIM barrel fold. 
Coordinates take from PDB file 1HZY. 
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Figure 1.2. Binuclear metal center of Phosphotriesterase representing the α and β metals 
bridged by the catalytic solvent molecule. Coordinates taken from PDB file 1HZY. 
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Figure 1.3. The substrate binding site of phosphotriesterase bound to the inhibitor diethyl 
4-methylbenzyl phosphonate. Residues in the small binding pocket are Gly60, Ile106, 
Ser308, and Leu303. The large binding pocket is defined by residues His254, His257, 
Met317, and Leu271. Residues in the leaving group pocket are Phe132, Trp131, Phe306 
and Tyr309. Coordinates taken from PDB file 1DPM. 
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Reaction Mechanism 
The catalytic mechanism for the hydrolysis of organophosphate triesters has been 
extensively studied.  The proposed mechanism of the bacterial PTE is presented in 
Figure 1.4.  The pH-rate profiles for the hydrolysis of paraoxon indicate that a single 
group must be deprotonated with a pKa of ~6.1 (Donarski et al., 1989).  The ionization 
observed in the pH-rate profiles must be associated with the enzyme since the substrate 
does not ionize in this pH range.   In addition, it has been demonstrated that the kinetic 
pKa is dependent on the identity of the divalent cation bound to the enzyme (Aubert et 
al., 2004).  These results are consistent with the utilization of a bridging hydroxide 
between the two divalent metal ions as the nucleophile during substrate turnover.   
The reactivity of the bridging hydroxyl is apparently enhanced by proton transfer 
to Asp-301.  Nucleophilic attack of the activated hydroxyl at the phosphorus center 
occurs with the expulsion of the leaving group.  His-254 is currently believed to assist 
the reaction by the shuttling of the proton from Asp-301 to the bulk solvent and away 
from the active site (Aubert et al., 2004).  Theoretical studies have suggested that Tyr-
309 could stabilize the p-nitrophenol leaving group through a hydrogen bonding 
interaction (Koca et al., 2001).  However, the mutation of Tyr-309 to a phenylalanine did 
not significantly affect the hydrolysis of organophosphate triesters by PTE and thus this 
potential interaction does not contribute to substrate turnover (Aubert et al., 2004). 
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Figure 1.4. The proposed catalytic mechanism for the hydrolysis of paraoxon by 
bacterial phosphotriesterase. 
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The chiral insecticide O-ethyl O-p-nitrophenyl phenylphosphonothioate (EPN) 
was utilized to determine the net stereochemistry at the phosphorus center during 
organophosphate hydrolysis by PTE.  It was determined that hydrolysis of the SP-
enantiomer of EPN by PTE results in the formation of the SP-enantiomer of the 
corresponding thiophosphonic acid (Lewis et al., 1988).  This result demonstrates that 
the reaction proceeds via an SN2-like mechanism with a net inversion of stereochemistry 
at the phosphorus center.  Therefore the reaction mechanism does not involve the 
formation of a phosphorylated enzyme intermediate.  The X-ray structure of PTE bound 
to the sarin analog, diisopropyl methyl phosphonate, has provided evidence for the 
proposed orientation of the substrate in the active site.  In this complex, the distance 
between the phosphoryl oxygen of the substrate and the more solvent exposed metal ion 
(β-metal) was 2.5 Å (Benning et al., 2000).  These results support the role of the β-metal 
to polarize the phosphoryl oxygen bond and enhance the electrophilicity of the 
phosphorus center.  
 
Substrate and Stereochemical Specificity 
 Although paraoxon is the best substrate known for PTE, the substrate specificity 
is very broad and covers a wide range of organophosphates, thiophosphates and 
phosphorothiolates.  For substrates with different leaving groups, the catalytic efficiency 
and the rate limiting step are dependent on the pKa of the leaving group (Hong and 
Raushel, 1996).  The substrate specificity of PTE was probed using a small library of 
paraoxon analogs as illustrated in Scheme 1.3.  All combinations of methyl, ethyl, 
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isopropyl and phenyl groups were substituted for the substituents X and Y, resulting in 
16 potential organophosphate substrates.  All of these paraoxon analogs were found to 
be substrates for PTE with turnover values ranging from 18,000 s-1 for dimethyl p-
nitrophenyl phosphate to 220 s-1 for the diisopropyl p-nitrophenyl phosphate (Hong and 
Raushel, 1999a).  The most interesting feature that emerged from this study was the 
inherent stereoselectivity of PTE.  The enzyme was found to preferentially hydrolyze the 
SP-enantiomer within a racemic mixture of chiral organophosphate triesters (Lewis et al., 
1988; Hong and Raushel, 1999b).  The stereoselectivity was more pronounced for the 
methyl isopropyl p-nitrophenyl phosphate, for which the efficiency of hydrolyzing the 
SP-enantiomer was 100-fold greater than for the corresponding RP-enantiomer (Hong and 
Raushel, 1999a).  This catalytic property is of significant interest since the toxicity of 
most organophosphate nerve agents is dependent on the stereochemistry at the 
phosphorus center (Benschop and De Jong, 1988).  From the crystal structure of PTE 
with a bound substrate analog, it was demonstrated that the substituents attached to the 
phosphorus center bind in a specific orientation within the active site, which is 
apparently dictated by the space available within the various subsites (Vanhooke et al., 
1996).  In all cases, the preferred stereoisomer is the one with the bulkier group 
represented by Y and the smaller group represented by X.  
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Scheme 1.3. Template used to probe the substrate specificity of PTE 
 
When these paraoxon analogs were screened for their ability to inactivate AChE, 
the RP-enantiomer was always a more potent inhibitor of AChE than the corresponding 
SP-enantiomer (Hong and Raushel, 1999a; Hong and Raushel, 1999b).  From a 
comparison of the absolute configuration of the nerve agent sarin and methyl diisopropyl 
p-nitrophenol phosphate, it was predicted that PTE would preferentially hydrolyze the 
less toxic RP-enantiomer of sarin over the more toxic SP-enantiomer.  The same trend in 
relative stereoselectivity was obtained for the hydrolysis of chiral organophosphates with 
a thiolate leaving group.  When a racemic mixture of the insecticide acephate was 
subjected to hydrolysis by PTE, the rate of hydrolysis of the SP-enantiomer was 
significantly higher than the RP-enantiomer (Chae et al., 1994).  However, the overall 
rates of hydrolysis of the P-S bond are substantially slower than the rates reported for the 
cleavage of P-O and P-F bonds (Chae et al., 1994). 
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Inactivation of Acetylcholinesterase 
 Acetylcholinesterase (AChE) is a remarkably efficient serine hydrolase.  It 
catalyzes the hydrolysis of the neurotransmitter acetylcholine (ACh) at cholinergic 
synapses (Figure 1.5).  The hydrolysis reaction is initiated by the nucleophilic attack of 
Ser-200 on the carbonyl center of ACh to form an acetylated enzyme intermediate that is 
coupled with the release of the first product, choline.  The free enzyme is regenerated by 
hydrolysis of the acetylated-enzyme intermediate and release of the second product, 
acetate.  In the presence of organophosphates, the active site Ser-200 is phosphorylated 
to form a phosphorylated enzyme intermediate.  In this case, the hydrolysis of the 
phosphorylated-enzyme intermediate is very slow.  If AChE is not reactivated by an 
oxime nucleophile such as 2-PAM, the phosphorylated enzyme intermediate can 
undergo a base-assisted dealkylation reaction resulting in formation of “aged” AChE that 
is permanently inactivated (Millard et al., 1999).  The half-time for aging is dependent 
on the nerve agent bound to the active site, pH and ionic strength (Berman and Decker, 
1986).   
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Figure 1.5. Acetylcholinesterase-catalyzed hydrolysis of acetylcholine at the cholinergic 
synapses.  Figure is available at the CNSforum web site at the following web address 
(http://www.cnsforum.com/imagebank/item/rcpt_sys_ACH_esterase/default.aspx). 
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 The toxicity of nerve agents is dependent on the stereochemistry at the 
phosphorus center.  Since sarin and VX have a single chiral center there are two 
stereoisomers in the racemic mixture (see Scheme 1.4).  However, in soman there is an 
additional stereogenic center within the pinacolyl group and thus soman consists of a 
mixture of four stereoisomers.  Although the racemic mixture of soman is a potent 
inhibitor of AChE, studies with mice have indicated that the two SP-diastereomers of 
soman are 100-fold more toxic than the corresponding RP-enantiomers (Benschop et al., 
1984).  A similar trend has been observed for sarin and VX where the SP-enantiomer is a 
more potent AChE inhibitor than the RP-enantiomer.  Table 1.1 lists the toxicity of 
individual isomers of sarin, soman and VX in terms of LD50 values and rate constants for 
the inhibition of AChE (Benschop and De Jong, 1988).  
 
 
 
 
 
 
 
 
 
Scheme 1.4. Individual stereoisomers of the verve agents sarin, soman, and VX. 
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Table 1.1. Toxicity of individual stereoisomers of organophosphate nerve agents from      
scheme 1.4 (Benschop et al., 1988). 
 
 
 
 
 
 
 
 
 
 
 
 
Nerve Agent Stereoisomer LD 50 (Mouse) 
μg/kg 
Inhibition Rate Constant 
(M-1min-1) 
RP-sarin  <3 x 103 
SP-sarin 41 1.4 x 107 
RPRC-soman >5000 <5 x 103 
RPSC-soman >2000 <5 x 103 
SPRC-soman 99 2.8 x 108 
SPSC-soman 38 1.8 x 108 
RP-VX 165 2 x 106 
SP-VX 12.6 4 x 108 
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Other Organophosphate Hydrolyzing Enzymes  
 Another group of enzymes involved in the detoxification of chemical warfare 
agents is the squid-type DFPases that have the ability to hydrolyze 
diisopropylfluorophosphate (DFP), sarin, soman, tabun, but not VX.  The crystal 
structure of the DFPase from Loligo vulgaris shows that the protein exists as a monomer 
and adopts a 6-fold β-propeller-like motif (Scharff et al., 2001).  DFPase contains high 
and low affinity Ca2+ binding sites that have been suggested to be involved in the 
hydrolytic reaction.  DFPase is very efficient for the detoxification of DFP with a kcat/Km 
value of 1.3 x 106 M-1s-1 (Hartleib and Rüterjans, 2001). 
 An organophosphorus acid anhydrolase (OpaA) from Alteromonas sp. JD6.5 was 
cloned and sequenced at the Edgewood Research, Development, and Engineering Center 
(Cheng et al., 1996). The natural function of OpaA has been proposed to be a 
dipeptidase that catalyzes the hydrolysis of dipeptides with a proline residue at the C-
terminus (Cheng et al., 1996).  OpaA also displays catalytic activity with 
organophosphate triesters including the nerve agents sarin and soman.  Unlike PTE, 
OpaA is unable to hydrolyze the nerve agent VX (Cheng et al., 1999).  The 
stereoselectivity of OpaA was surveyed with the same library of paraoxon analogs that 
has been used for PTE.  Like PTE, OpaA preferentially hydrolyzes the SP-enantiomers of 
the organophosphate triesters shown in Scheme 1.3, although the overall catalytic 
efficiency is significantly lower than for PTE (Hill et al., 2000).  Similarly, OpaA 
displays a stereoselective preference toward the hydrolysis of the least toxic RP-
enantiomers of sarin and soman analogs (Hill et al., 2001).   
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 Another prolidase that was identified as an enzyme capable of degrading 
organophosphates is the E. coli aminopeptidase P (PepP).  PepP is a metalloprotein that 
requires two Mn2+ cations for catalysis.  The enzyme functions as a tetramer that adopts 
a “pita-bread” fold similar to methionine aminopeptidase and creatinase (Wilce et al., 
1998).  The ability of PepP to hydrolyze organophosphate triesters was probed with a 
small library of racemic paraoxon analogs. The highest rates were observed for the 
substrates containing the substituents methyl-isopropyl and methyl-isobutyl (Jao et al., 
2004).  
 
PTE-Catalyzed Detoxification of Organophosphorus Compounds 
 Currently, decontamination of organophosphates relies on bleach treatment, 
alkaline hydrolysis, or incineration.  In all cases, the conditions are harsh and the 
byproducts can be toxic.  Therefore, efforts have been directed toward enzyme-catalyzed 
decontamination and bioremediation.  The use of bio-scavengers, such as the exogenous 
administration of acetyl cholinesterase (Saxena et al., 1997) or human butyryl 
cholinesterase (Raveh, et al., 1997) has proven affective for protection against 
organophosphate poisoning.  These reagents exert their function by binding to the nerve 
agents and preventing them from reaching their target.  The disadvantage associated with 
this approach is the large amount of scavenger required for optimum protection, since 
these enzymes have a binding stoichiometry of unity.  Therefore, attention has been 
drawn to enzymes that can catalytically hydrolyze organophosphate nerve agents.   
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Due to a broad substrate specificity and stereoselectivity, PTE is a promising 
candidate for in vivo and in vitro detoxification of organophosphate nerve agents.  
Animal studies in mice showed that intravenous injection with 1.5 IU (paraoxonase 
activity of 1.5 μmol/min) of PTE before or immediately after the administration of 
paraoxon protected brain AChE activity against inhibition by paraoxon (Kaliste-
Korhonen et al., 1993).  When PTE was injected 10 minutes before administration of 
paraoxon, the concentration required to decrease the activity of brain AChE to 40% of 
the control was increased from 0.5 mg paraoxon/Kg to 20 mg paraoxon/Kg (Kaliste-
Korhonen et al., 1993). 
The slower rates of sarin, soman, and DFP hydrolysis by PTE were reflected in 
the in vivo study.  In the case of DFP exposure, PTE treatment protected slightly the 
activity of brain AChE, but not the serum AChE (Tuovinen et al., 1994).  However, 
when the two Zn2+ ions in the binuclear metal center were replaced by Co2+, the 
protection of AChE against DFP inhibition was enhanced (Tuovinen et al., 1996a).  The 
total plasma paraoxon hydrolyzing activity for the Co2+-reconstituted PTE was 
approximately 10-fold higher than the Zn2+-enzyme.  The intravenous injection of 6.9 μg 
PTE/g 10 minutes after exposure to 1.8 mg DFP/kg retained AChE activity of 90% of 
the control for up to 6 hours, which was better than the protection effect of the 
carbamate, eptastigmine (Tuovinen et al., 1996b).  If the same dose of PTE was injected 
30 minutes after exposure, the protection of AChE dropped to 40% after 6 hours and 
15% after 24 hours (Tuovinen et al., 1996c).  These data are similar to the protection 
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rates obtained for eptastigmine.  Therefore, it was concluded that PTE treatment is much 
more effective during the first few minutes after exposure.    
PTE pretreatment did not significantly protect brain or serum AChE against sarin 
or soman toxicity (Tuovinen et al., 1994).  However, it increased the sarin dose required 
to induce inactivation of AChE.  A relatively high dose of PTE (104 U/g body weight) 
increased the LD50 of sarin toxicity from 1.4 mg/kg to 4.7 mg/kg (Tuovinen et al., 1999).  
When the same dose of PTE was combined with 0.09 mg/kg body weight of the 
carbamate, physositigmine, the LD50 was further increased to 6.0 mg/kg (Tuovinen et al., 
1999).  When PTE was incubated in vitro with mouse serum that was treated with 
paraoxon, the AChE activity was recovered from 25-31% to 76-100 % of control activity 
in 24 hours (Tuovinen et al., 1994).  The overall results from animal studies indicated 
that PTE-pretreated animals can tolerate 50-fold higher doses of paraoxon than the 
untreated animals.   
The biological distribution of PTE using [125I] labeling indicated that the enzyme 
was found in the liver, kidney, and lungs, but not in the nervous system. This suggests 
that PTE hydrolyzes organophosphates in circulation before reaching the nervous system 
(Tuovinen et al., 1996a).  The in vivo therapeutic application of PTE is restricted by its 
half-life in plasma, which was reported to be approximately 5 hours (Tuovinen et al., 
1996a).  To overcome this limitation, attempts have been made to encapsulate PTE in 
biodegradable carriers.  PTE was successfully encapsulated within murine erythrocytes 
by hypotonic dialysis (Pei et al., 1994) and within sterically stable liposomes 
(Petrikovics et al., 1999) to antagonize paraoxon toxicity.  
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Altering Substrate Specificity and Directed Evolution of PTE 
PTE has been subjected to several rational design and directed evolution studies 
to optimize the active site for enhanced detoxification of organophosphates and the 
related organophosphonate nerve agents.  The stereo-specificity displayed by PTE 
initiated a series of investigations to reshape the substrate binding site by utilizing site 
directed mutagenesis for enhanced, relaxed or reversed stereoselectivity.  The first set of 
experiments was based on the mutation of all residues that define the hydrophobic 
substrate binding site to alanine, and a subsequent investigation of the impact of these 
alterations on the stereoselectivity of PTE.  For the residue Gly-60, which is located in 
the small binding pocket, mutation to alanine significantly enhanced the substrate 
stereoselectivity (Chen-Goodspeed et al., 2001a).  For example, the ratio for hydrolysis 
of the chiral methyl phenyl p-nitrophenyl phosphate by wild type PTE is 90 in favor of 
the SP-enantiomer over the RP-enantiomer (Hong and Raushel, 1999a).  The G60A 
mutant of PTE displayed a 100-fold reduction in kcat/Km for the RP-enantiomer and 
therefore, the ratio of stereoselectivity was enhanced to 13,000 in favor of the SP-
enantiomer (Chen-Goodspeed et al., 2001a).  Mutations of the large subsite residues, 
His-245, His-257, Leu-271 and Met-317 to alanine had no impact on the 
stereospecificity.  These data suggest that the substrate specificity is mainly dictated by 
the steric constraints within the small binding pocket (Chen-Goodspeed et al., 2001a).  
These studies were further extended to include other mutations that can 
reconstruct the active site of PTE.  The mutation I106G in the small subsite relaxed the 
stereoselectivity for hydrolysis of chiral methyl phenyl p-nitrophenyl phosphate from 
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90:1 to 1.7:1 (Chen-Goodspeed, et al., 2001b).  This result was achieved by increasing 
the kcat/Km for the hydrolysis of the RP-enantiomer 100-fold over the wild type enzyme.  
The stereoselectivity was reversed by simultaneously enlarging the small subsite and 
shrinking the large subsite.  While the wild type enzyme prefers the SP-enantiomer of 
methyl phenyl p-nitrophenyl phosphate by a factor of 90, the mutant 
I106G/F132G/H257Y/S308G prefers the RP-enantiomer by a factor of 190. The same 
mutant displays a preference for the RP-enantiomer of chiral ethyl phenyl p-nitrophenyl 
phosphate over the SP-enantiomer with a ratio of 80:1 (Chen-Goodspeed, et al., 2001b).  
A novel application based on these findings was to utilize PTE variants with enhanced 
and reversed stereospecificity for efficient synthesis of chiral organophosphate triesters. 
The mutants G60A and I106A/F132A/H257Y were successfully used to kinetically 
resolve racemic mixtures of chiral paraoxon analogs with an enantiomeric excess of 
approximately 95-99 % (Wu et al., 2000).   
PTE is of interest owing to its ability to catalytically hydrolyze the nerve agents 
sarin, soman and VX.  Since these agents are not readily available for research use, 
analogs have been synthesized to help screen for optimized variants of PTE toward the 
detoxification of organophosphonates (Figure 1.6).  For sarin and soman, chromogenic 
analogs were obtained by substituting the fluoride leaving group with a p-nitrophenyl 
group.  For VX, prochiral analogs were synthesized with slight modifications in the 
thiolate leaving group.  The toxicity of these analogs was assessed in terms of minimum 
effective concentration (MEC) using a simple and cost efficient bioassay in Hydra 
attenuata (Lum et al., 2003).   The individual toxicity of sarin, soman and VX was 
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reflected in the toxicity of their analogs with two of the VX analogs being the most toxic 
(Table 1.2).  For the chiral sarin analogs, the SP-enantiomer was approximately 4 orders 
of magnitude more toxic than the RP-enantiomer (Lum et al., 2003). 
Very promising and interesting results were obtained when the chiral sarin and 
soman analogs were used to evaluate the potential of PTE for stereoselective 
detoxification of nerve agents.  As expected from previous stereoselectivity profiles, 
wild type PTE preferentially hydrolyzes the least toxic RP-enantiomer of the sarin analog 
10-fold better than the more toxic SP-enantiomer.  This preference was reversed by the 
mutant I106A/F132A/H257Y, which showed an enhanced rate of hydrolysis of the SP-
enantiomer by a factor of 30 (Li et al., 2001).  A similar trend was observed for the 
soman analogs.  These data clearly demonstrate that the active site of PTE can be 
manipulated for optimum decontamination and decomposition of the neurotoxins, sarin 
and soman.  
  
 
 
 
 
 
 
 
 
 24
 
 
 
 
 
Figure 1.6. Structures of synthetic analogs of the nerve agents sarin, soman, and VX. 
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Table 1.2. Toxicity of organophosphate analogs that appear in Figure 1.6 (Lum, et al., 
2003). 
Compound MEC 92th (mg/L) 
p-nitrophenol 9.4 x 101 
paraoxon 2.5 x 101 
(Rp)-GB p-NP 1.0 x 102 
(Rp/Sp)-GB p-NP 2.0 x 10-2 
(Sp)-GB p-NP 1.3 x 10-2 
(RpRc/RpSc/SpRc/SpSc)-GD p-NP 2.5 x 10-4 
(SpRc/SpSc)-GD p-NP 2.0 x 10-4 
(SpSc)-GD p-NP 8.5 x 10-5 
Ecothiophate iodide 1.0 x 10-4 
Diethyl VX 3.0 x 10-6 
Tetriso 3.1 x 10-6 
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A semi-rational approach was taken to expand the search for PTE mutants with 
enhanced activity for the hydrolysis of chemical warfare agents. The active site residues 
were randomly mutated by saturation mutagenesis and variants were screened using a 
crude cell assay.  Screening with the most toxic p-nitrophenyl soman analog resulted in 
the isolation and identification of the mutant H254G/H257W/L303T which has a rate 
enhancement of approximately 3 orders of magnitude over the wild type enzyme (Hill et 
al., 2003).  It was noted from the mutagenesis experiments on PTE that the large subsite 
residue, His-257, is significant for modifying the substrate specificity.  Another PTE 
homolog (opdA) was recently isolated from Agrobacterium radiobacter P 230 (Horne et 
al., 2002) that shares a 90% sequence identity with PTE from P. diminuta.  The major 
difference between PTE and opdA is the presence of Arg and Tyr at positions 254 and 
257 respectively instead of His in PTE.  In a directed evolution study, the opd gene was 
shuffled in a search for enhanced variants for methyl parathion hydrolysis. The mutation 
H257Y was found in all isolates that displayed higher activities (Cho et al., 2002).  The 
highest activity was obtained by introducing 7 different mutations, with only the 
mutation H257Y located in the active site.  The large subsite was target for a rational 
design experiment that led to the identification of the mutant H254R/H257L, which had 
20-fold enhancement over wild type for the VX analog demeton-S (Di Sioudi et al., 
1999). 
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Potential Applications 
The current methods for the detoxification of organophosphorus compounds are 
harmful and possess serious environmental consequences.  Therefore, utilizing enzymes 
for the detection and decontamination of organophosphate agents has received 
considerable attention.  PTE has been recognized as a potential candidate for extending 
the process of organophosphate detoxification.  The insecticides paraoxon and parathion 
were successfully hydrolyzed by PTE that was immobilized on a trityl agarose matrix 
(Caldwell and Raushel, 1991a).  The immobilization resulted in a relative increase in the 
stability of PTE and the maximum efficiency of the system was about 40%, relative to 
the free enzyme.  The immobilized enzyme exhibited a similar kinetic profile to the free 
enzyme with a 3-fold higher Km for paraoxon (Caldwell and Raushel, 1991a).  Since 
immobilization of PTE on trityl agarose was based on hydrophobic interactions, the use 
of organic solvents to solubilize the pesticides was problematic and weakened the 
interaction between the enzyme and the solid support.  This limitation was overcome by 
covalently immobilizing PTE on nylon tubing, powder, and membranes (Caldwell and 
Raushel, 1991b).  In this case, methanol was used as a solvent at a concentration up to 
40% with no adverse effect on the activity of PTE, which allowed hydrolysis of very 
high substrate concentrations. The amount of PTE immobilized was dependent on the 
surface area of the membrane and was limited to 390 U for a 48 cm2 nylon 66 
membrane.  This amount was significantly increased to 9000 units for a 2000 cm2 nylon 
6 membrane.  The catalytic efficiency of the 11 U nylon 66 membrane reactor in the 
presence of 0%, 10%, and 40% methanol were reduced to 4% of the soluble enzyme 
 28
activity under the same reaction conditions (Caldwell and Raushel, 1991b).  This low 
efficiency could be attributed to the internal diffusional effect since hydrolysis of 
paraoxon by soluble PTE achieves the diffusion control limits.  PTE immobilized on 
nylon powder (240 U/ 750 mg nylon 11 powder), was stable for as long as 20 months at 
5 °C.  A reactor of 900 PTE units immobilized onto 2.5 g of the nylon 11 powder could 
hydrolyze 18.3 mM paraoxon in 30% methanol at a rate of 76 μmol/min (Caldwell and 
Raushel, 1991b).   
Another study to develop a delivery method for use of PTE in the 
decontamination of organophosphates involved incorporating PTE within fire fighting 
foams.  Foams containing PTE displayed high capacity for surface decontamination.  A 
1.2 cm foam height containing 11.4 nM PTE could detoxify a surface contaminated with 
1.15 μmol paraoxon/cm2 with 43% conversion (LeJeune and Russell, 1999).  When the 
foam height was increased to 3.0 cm, the conversion was enhanced to 70%.  To test the 
ability of PTE foams to decontaminate soil, two sand columns were contaminated with 
2.3 μmol/g paraoxon.  While soluble PTE was applied to one column, an equal amount 
of enzyme activity was immobilized onto the foam and applied to the second column.  
By analyzing the products, it was determined that the column treated with the PTE foam 
had a 85% conversion in 1 hour, while the column treated with soluble PTE displayed 
less than 50% conversion (LeJeune and Russell, 1999).  In addition, nanocomposites of 
PTE adsorbed on isocyanatopropyl-silica and poly hydroxymethylsiloxane (PHOMS) 
were shown to be effective in detoxifying liquid and gas phase organophosphates (Gill 
and Ballesteros, 2000). 
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The extensive use of organophosphates necessitated the need to develop devices 
for early detection and quantification of organophosphates in contaminated areas.  AChE 
inhibition based biosensors have been used to monitor organophosphate exposure.  
Although, AChE-biosensors are very sensitive, they are not selective since AChE is 
inhibited by a wide range of compounds including carbamates.  In addition, AChE 
sensors are based on very complicated procedures and cannot be regenerated because of 
irreversible inhibition.  PTE-based devices were developed based on the products of the 
hydrolysis reaction.  For example, the hydrolysis of paraoxon by PTE releases two 
protons and a chromophoric leaving group, which can be utilized for the design of 
potentiometric and optical biosensors, respectively.  To develop a PTE based 
potentiometric biosensor, a pH glass electrode was modified by immobilizing purified 
PTE.  Concentrations of paraoxon, parathion, and methyl parathion as low as 2 μM were 
detected using a 500-unit PTE electrode (Mulchandani et al., 1999a).  Based on the same 
principle, a PTE potentiometric biosensor was developed by immobilizing recombinant 
E. coli cells harboring the opd gene instead of purified protein (Rainina et al., 1996).  A 
fluorescent biosensor was developed based on the change of pH resulting from 
hydrolysis of organophosphates by using fluorescein isothiocyanate (FITC) modified 
PTE.  The FITC-PTE was adsorbed on polymethyl methacrylate beads, and the decrease 
in the fluorescent intensity of FITC was measured as the enzymatic hydrolysis proceeds 
(Roger et al., 1999).  A broad scope of organophosphates could be detected by this 
methodology including parathion, diazinon, methylparathion and coumaphos.   
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A fiber-optic enzyme biosensor (FOEB) of PTE was designed based on the 
reaction products that can be detected spectrophotometrically. The biosensor contained a 
monochromator with a wavelength cutoff of 400 nm (for the p-nitrophenol leaving group 
of paraoxon and parathion) and a cutoff of 348 nm for the hydrolysis product of 
coumaphos (Mulchandani et al., 1999b).  PTE was immobilized by covalent cross-
linking with glutaraldehyde on a 0.45 μm pore size nylon membrane.  The detection 
limit for this FOEB was 2 μM paraoxon, which is comparable to the potentiometeric 
biosensors.  
Despite their great potential, the detection limit of PTE biosensors was much 
higher than the AChE-based devices.  An amperometric biosensor was developed based 
on electrochemical oxidation of the p-nitrophenol (pNP) released from PTE-catalyzed 
hydrolysis (Mulchandani et al., 1999c).  The electrode was composed of purified PTE 
immobilized onto a printed carbon surface.  The oxidation current was directly 
proportional to the level of pNP released. Unlike the potentiometric and optical 
biosensors, the detection limits for this device were significantly low, 0.7 nM and 0.9 
nM for methyl parathion and paraoxon respectively (Mulchandani et al., 1999c).  The 
same principle was applied to develop a microbial amperometric biosensor based on the 
immobilization of whole cells expressing PTE anchored to the outer membrane by 
fusion to the ice nucleation protein from Pseudomonas syringae (Mulchandani et al., 
2001).  It was determined that the microbial biosensor offered sufficient selectivity and 
that other cellular or environmental chemicals did not interfere with the sensor detection. 
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This technology provides a cost efficient, simple, reliable and rapid detection of 
organophosphate pesticides and nerve agents.   
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CHAPTER II 
EVOLUTION OF PHOSPHOTRIESTERASE FOR EFFICIENT 
DETOXIFICATION OF THE NERVE AGENT VX 
  
Introduction 
 
Historical Background  
 
 Among the known lethal chemical warfare agents, the V-type agents are the most 
toxic nerve agents known.  Their discovery started in the 1950’s when Dr. Ranajit 
Ghosh, a chemist at the Plant Protection Laboratories of the British firm Imperial 
Chemical Industries (ICI), was investigating a class of organophosphate compounds 
(organophosphate esters of substituted aminoethanethiols) as potential agricultural 
pesticides.  In 1954, the ICI released the compound Amiton® (1 in Scheme 2.1) to the 
market as an effective pesticide.  Amiton, also known as VG, was shortly withdrawn 
after its release for its extreme toxicity.  Consequently, the CW British facility at Porton 
Down adopted the technology and started producing the new class of nerve agent, V-
class, for military use.  The best known agent in this class is VX (2).  When the Russians 
took on the synthesis of V-agents, they synthesized a derivative of VX and called it 
Russian-VX (RVX), also known as V-gas (3).  The US started producing and stockpiling 
VX in 1961 (Organization for the Prohibition of Chemical Weapons, OPCW). 
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Scheme 2.1. Chemical Structures of the V-series nerve agents. 
 
 The V-series agents are known to be more lethal and persistent than the G-class 
agents (sarin and soman).  However, the irreversible inhibition of acetylcholinesterase  
(aging) caused by VX occurs with a significantly longer half-life of approximately 2 
days compared to a half-life of 1-10 minutes in case of soman.  Due to the serious 
environmental and health risks associated with organophosphates, efforts have been 
devoted to the biodegradation and bioremediation of this series of compounds.     
 Among enzymes that catalytically hydrolyze organophosphate triesters, the 
phosphotriesterase from Flavobacterium sp. (PTE) is the only enzyme known to catalyze 
the hydrolysis of organophosphono thiolates such as the lethal nerve agents VX and R-
VX (Kolakowski et al., 1997).  However, the catalytic efficiency is significantly lower.  
For example, the kcat/Km values for paraoxon and VX hydrolysis by PTE are 6 x 106  
M-1s-1 and 45 M-1s-1, respectively.   
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Protein Engineering   
 Protein engineering has been widely used to create novel enzymes with enhanced 
activity, stability and/or substrate specificity.  Two approaches are currently available; 
rational design, and directed evolution.   Rational design involves precise changes in the 
amino acid sequence using site directed mutagenesis (SDM).  This technique is mainly 
based on a good understanding of protein structure, function, and mechanism.  Unlike 
rational design, directed evolution does not require detailed knowledge of the protein 
structure.  Molecular diversity is achieved by multiple rounds of random mutagenesis or 
recombination of a target gene followed by screening or selection for desired variants.   
Error-prone PCR (ep-PCR), DNA shuffling, saturation mutagenesis, and E.coli mutator 
strains are among the different strategies for in vitro evolution.    
 EP-PCR reaction utilizes an “error-prone” DNA polymerase.  Taq polymerase is 
the most commonly used enzyme for this purpose.  In addition, the reaction mixture 
contains manganese chloride instead of magnesium chloride (Cadwell et al., 1992).   
Manganese chloride was shown to have a significant mutagenic effect on several 
polymerases (Beckman et al., 1985).  The overall error rate is 1-2 base substitutions for 
each generation.  EP-PCR was successfully combined with saturation mutagenesis to 
evolve a bacterial lipase from P. aeruginosa.  Six rounds of random mutagenesis 
resulted in an enzyme with a 25-fold enhancement in enantioselectivity over wild type 
(Liebeton et al., 2000).   
 DNA shuffling as a technique for in vitro evolution via gene reassembly was 
developed by W. P. Stemmer in Maxygen, Inc. (Stemmer, 1994).  In this method, a 
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population of genes containing beneficial mutations are randomly digested by DNase I 
into a pool of 10-50 nucleotide fragments.  The fragments then are self-primed, based on 
homology, using PCR.  Not only does DNA shuffling accelerate the process of 
molecular breeding, it also provides a very flexible technique that can be applied for a 
single gene shuffling (Stemmer, 1994), homologous genes shuffling, “family shuffling” 
(Crameri et al., 1998), or whole-genome shuffling (Zhang et al., 2002). 
 In this chapter, PTE is subjected to directed evolution experiments by employing 
the semi-rational design approach in an attempt to engineer the substrate binding site for 
enhanced degradation of synthetic analogs of the nerve agent VX (Scheme 2.2).  Since 
the Amiton analog, diisopropyl amiton (DEVX 4) is more structurally related to the 
nerve agent VX, this investigation will be more focused on the hydrolysis of this 
substrate.   
 
  
 
 
Scheme 2.2. The structures of VX analogs used in this study. 
 
Materials and Methods 
Materials 
  QuickChange® site directed mutagenesis kit was purchased from Stratagene.   
E. coli BL21-DEIII, XL1-Blue cells and the Bugbuster cell lysis reagent were purchased 
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from Novagen.  Wizard-Plus SV miniprep DNA Purification System was obtained from 
Promega.  All restriction enzymes and T4 DNA ligase were obtained from New England 
Biolabs.  Demeton-S was purchased from Chem. Service.  The VX analog, diisopropyl 
amiton (DEVX) was synthesized in our laboratory by Dr. Yingchun Li.  The medium 
copy number expression vector, pZA32-luc (Figure 2.1), was a gift from Dr. Ryland 
Young, Department of Biochemistry & Biophysics.  Oligonucleotides were synthesized 
by the Integrated DNA Technologies (IDT). DNA sequencing was performed in the 
Gene Technologies Lab. (GTL), Texas A&M University. All other materials were 
purchased from Sigma. 
 
Construction of Single Substitution Libraries 
 The plasmid, pJames, served as the template for constructing the single 
substitution libraries.  Twelve libraries targeting amino acid residues that define the 
substrate binding site of PTE were created using the Quick Change site directed 
mutagenesis technique. Oligonucleotides containing the degenerate codon NNS at a 
specific site were used to eliminate two stop codons, TGA and TAA.  PCR products 
were transformed in E. coli XL1-blue electro-competent cells for DNA sequencing.  
Colony forming units (CFU’s) obtained from each library were sequenced until all 
mutagenesis possibilities were identified for each position, resulting in a combinatorial 
library of 228 plasmids in addition to wild type. 
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Figure 2.1. A map of the pZA32-Luc plasmid showing the chloramphenicol resistance 
gene and the ptac promoter.  The opd gene was inserted between the KpnI and AvrII 
restriction sites. 
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 Construction of Third Generation Libraries in the H254Q/H257F Template 
 Libraries in the H254Q/H257F parent were constructed as described above.  Due 
to the inconsistency in protein expression associated with the high copy number pBS(+) 
vector,  the plasmid pZA32-QF served as the template for the subsequent libraries.  To 
construct pZA32-QF, the opd gene was amplified from the plasmid pJK01 using the 
primers pJK01-5’-Kpn I, 5’-
CGCGCCGGGTACCATGTCGATCGGCACAGGCGATCGG, and pJK01-3’-Avr II, 
5’- CCGGGTACCCCTAGGTCATCATCATGACGCCCGCAAGGTC. The 1000 bp 
PCR product was purified, digested with Kpn I and Avr II and ligated in the 
chloramphenicol resistant plasmid pZA32-Luc resulting in the construct pZA32-opd.  
The double mutation H254Q/H257F was constructed in pZA32-opd using Quick Change 
mutagenesis resulting in the construct PZA32-QF, which was utilized to randomize the 
remaining 10 residues in the substrate binding pocket of PTE.  
 
Kinetics Measurements 
All kinetic measurements and screening were performed on a SPECTRAmax-
340 plate reader (Molecular Devices Inc, Sunnyvale CA).  For the paraoxon assays, 
release of p-nitrophenol (ε400 = 17,000 M-1cm-1) was monitored at pH 9.0.  For the VX 
analogs, the DTNB reaction (Ellman Assay) was utilized, and the formation of the thiol 
anion (ε412 = 14,150 M-1cm-1) was monitored at pH 8.0 (Scheme 2.3).   
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Scheme 2.3. Detection of free thiols using the DTNB reagent. 
 
Kinetic parameters were obtained by fitting the data to equation 1 where v is the initial 
velocity, Vmax is the maximal velocity, S is substrate concentration, and Km is the 
Michaelis constant.   
                   v = Vmax [S]/Km + [S]                                                            (1)  
                                        
Growth Conditions 
Single colonies obtained from transforming the mutagenesis product were 
inoculated in 96-deep well growth blocks containing 0.75 mL super broth (SB) 
supplemented with 0.5 mM CoCl2, and 0.1 mg/mL ampicillin or 25μg/mL 
chloramphenicol.  The culture blocks were incubated for 30-36 hours at 30 °C, shaking 
at 250 rpm.  In the case of single substitution libraries, each block contained two copies 
of each variant and controls, therefore, 12 libraries were grown in a total of 6 growth 
blocks.  In addition to PTE variants, each block included a set of standards with known 
catalytic parameters. Standards used are wild type, H254A, H254Q/H257F, 
I106A/F132A/H257Y (AAY), H254G/H257W/L303T (GWT), and BL21-DEIII cells.    
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Screening 
 The culture was diluted 10-fold with MQ water and cell density was measured 
spectrophotometrically at 600 nm.  The OD600 for 10-fold diluted culture ranged from 
0.5-0.7.  The paraoxon screen contained 10 μL diluted culture, 0.1 mM substrate, 50 mM 
CHES buffer, pH 9.0, and 2.0 % (v/v) Bugbuster. The release of p-nitrophenol was 
monitored spectrophotometrically at 25 °C.  The final conditions for the DEVX (4) 
screen were 50 μL diluted culture, 0.2 mM substrate, 50 mM HEPES buffer, pH 8.0, 0.3 
mM DTNB, and 2 % (v/v) Bugbuster.  Release of the thiolate anion is monitored 
spectrophotometrically at 412 nm.  Since the rate of DEVX hydrolysis is very slow 
compared to paraoxon, the results from the DEVX screens are recorded in an end point 
format.  The initial OD412 was subtracted from final OD412 after six-hour incubation at 25 
°C.  In all crude screens, rates were normalized to cell density.   
 
Protein Purification  
 Wild type and mutants of PTE were expressed in E. coli BL21-DEIII cells and 
grown in terrific broth (TB) supplemented with 1.0 mM CoCl2 and the appropriate 
antibiotic.  After 24-hour incubation at 30 °C, protein expression was induced by the 
addition of 1.0 mM isopropyl-β-thiogalactoside (IPTG) and cells were grown for 
additional 36-40 hours.  PTE was purified according to the previously published protocol 
(Omburo et al., 1992).   
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Results 
Screening of the Double Substitution Library, H254X/H257X 
 The double substitution library, H254X/H257X was constructed by Dr. Craig 
Hill in an attempt to engineer the active site of PTE to enhance the catalytic efficiency 
towards the hydrolysis of p-nitrophenol analogs of the nerve agent soman (Hill et al., 
2003).  Twelve growth blocks were screened for the hydrolysis of paraoxon and the VX 
analog, DEVX.  The standards included is this library were wild type in positions 19 & 
22 and H254A in positions 43 & 46.  Graphical representation of screening results for 
block 3 is shown in Figure 2.2.  Two variants were isolated from this block for enhanced 
activity over wild type.  They were identified as H254G/H257F and H254Q/H257F with 
the later being the highest.  H254Q/H257F (QF) served as a template for subsequent 
rounds of random mutagenesis.      
 
Single Substitution Libraries 
Single substitution libraries were constructed for positions Gly60, Ile106, 
Leu303, Ser308, Trp131, Phe132, Phe306, Tyr309, His245, His257, Leu271,  and 
Met317.  All nineteen substitution possibilities at each position were identified by DNA 
sequencing and inoculated in 96-deep well culture blocks.  Each block was screened 
with 0.1 mM paraoxon and 0.2 mM DEVX.  Table 2.1 shows the distribution of the 
G60X and I106X libraries in the 96-deep well block.  Figure 2.3A and B shows the 
screening results with paraoxon and DEVX, respectively.   
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Figure 2.2. Screening results for block 3 of the H254X/H257X double substitution 
library. The library was screened with 0.2 mM DEVX (4). 
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Table 2.1. Positions of members of the G60X and I106X single substitution libraries.  
Standards (in red) were wild type, H254A, H254Q/H257 (QF), I106A/F132A/H257Y 
(AAY), H254G/H257W/L303T (GWT), and BL21 cells. 
 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 
G60A 
9 
G60F 
17 
G60K 
25 
G60P 
33 
G60S 
41 
G60Y 
49 
I106D 
57 
I106H 
65 
I106M 
73 
I106R 
81 
I106V 
 
89 
B 2 
G60A 
10 
G60F 
18 
G60K 
26 
G60P 
34 
G60S 
42 
G60Y 
50 
I106D 
58 
I106H 
66 
I106M 
74 
I106R 
82 
I106V 
 
90 
C 3 
G60C 
11 
WT 
19 
G60L 
27 
H254A 
35 
G60T 
43 
QF 
51 
I106E 
59 
AAY 
67 
I106N 
75 
GWT 
83 
I106W 
 
91 
BL21 
D 4 
G60C 
12 
G60H 
20 
G60L 
28 
G60Q 
36 
G60T 
44 
I106A 
52 
I106E 
60 
I106K 
68 
I106N 
76 
I106S 
84 
I106W 
 
92 
E 5 
G60D 
13 
G60H 
21 
G60M 
29 
G60Q 
37 
G60V 
45 
I106A 
53 
I106F 
61 
I106K 
69 
I106P 
77 
I106S 
85 
I106Y 
 
93 
F 6 
G60D 
14 
WT 
22 
G60M 
30 
H254A 
38 
G60V 
46 
QF 
54 
I106F 
62 
AAY 
70 
I106P 
78 
GWT 
86 
I106Y 
 
94 
BL21 
G 7 
G60E 
15 
G60I 
23 
G60N 
31 
G60R 
39 
G60W 
47 
I106C 
55 
I106G 
63 
I106L 
71 
I106Q 
79 
I106T 
 
87 95 
H 8 
G60E 
16 
G60I 
24 
G60N 
32 
G60R 
40 
G60W 
48 
I106C 
56 
I106G 
64 
I106L 
72 
I106Q 
80 
I106T 
 
88 96 
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Figure 2.3. Results from the crude screen for the G60X and I106X single substitution 
libraries.  The block was screened with paraoxon (A) and DEVX (B). 
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The relative paraoxonase activity profile obtained from the crude assay is 
comparable to the kinetic parameters for previously purified PTE mutants.  For example, 
the kcat/Km (M-1s-1) values for wild type, G60A, I106A, and I106G are 6.4 x 107, 4.2 x 
107, 3.8 x 107, and 5.5 x 107, respectively (Chen-Goodspeed et al., 2001a, 2001b).  As 
can be observed from the screen, the order of activity is that G60A is similar to I106A, 
which is lower than I106G, which is less than wild type.  The activity of I106S towards 
paraoxon hydrolysis was slightly higher that the wild type.  Screening with DEVX did 
not show any enhancement compared to the standard, QF.   
The block containing H254X and W131X single substitution libraries was 
similarly screened with paraoxon and DEVX. Table 2.2 shows the location of each 
variant relative to the controls.  The screening results are shown in Figure 2.4A and B.  
The rate of the standard wild type was approximately 20% less than the average rate.  
Two variants had higher activity with paraoxon than the wild type; H254K and W131V.  
Purified W131A has a kcat/Km value of 8.3 x 106 M-1s-1, which is approximately 10-fold 
lower than wild type (Chen-Goodspeed et al., 2001a,b).  However, on the screen, it 
appears to have similar activity to wild type.  This could be due to different levels of 
protein expression in the growth blocks.  The relative activities of controls toward 
DEVX hydrolysis were similar to the G60X, I106X block.  In addition, the rate obtained 
for H254A in positions 1 and 2 was comparable to the rate obtained for the H254A 
control.  None of the variants was higher than the control, QF with DEVX.   
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Table 2.2. Positions of members of the H254X and W131X single substitution libraries.  
Standards (in red) are wild type, H254A, H254Q/H257F (QF), I106A/F132A/H257Y 
(AAY), H254G/H257W/L303T (GWT), and BL21 cells. 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 
H254A 
9 
H254F 
17 
H254K 
25 
H254P 
33 
H254S 
41 
H254Y 
49 
W131D 
57 
W131H 
65 
W131L 
73 
W131Q 
81 
W131T 
 
89 
B 2 
H254A 
10 
H254F 
18 
H254K 
26 
H254P 
34 
H254S 
42 
H254Y 
50 
W131D 
58 
W131H 
66 
W131L 
74 
W131Q 
82 
W131T 
 
90 
C 3 
H254C 
11 
WT 
19 
H254L 
27 
H2554A 
35 
H254T 
43 
QF 
51 
W131E 
59 
AAY 
67 
W131M 
75 
GWT 
83 
W131V 
 
91 
BL21 
D 4 
H254C 
12 
H254G 
20 
H254L 
28 
H254Q 
36 
H254T 
44 
W131A 
52 
W131E 
60 
W131I 
68 
W131M 
76 
W131R 
84 
W131V 
 
92 
E 5 
H254D 
13 
H254G 
21 
H254M 
29 
H254Q 
37 
H254V 
45 
W131A 
53 
W131F 
61 
W131I 
69 
W131N 
77 
W131R 
85 
W131Y 
 
93 
F 6 
H254D 
14 
WT 
22 
H254M 
30 
H254A 
38 
H254V 
46 
QF 
54 
W131F 
62 
AAY 
70 
W11N 
78 
GWT 
86 
W131Y 
 
94 
BL21 
G 7 
H254E 
15 
H254I 
23 
H254N 
31 
H254R 
39 
H254W 
47 
W131C 
55 
W131G 
63 
W131K 
71 
W131P 
79 
W131S 
 
87 95 
H 8 
H254E 
16 
H254I 
24 
H254N 
32 
H254R 
40 
H254W 
48 
W131C 
56 
W131G 
64 
W131K 
72 
W131P 
80 
W131S 
 
88 96 
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Figure 2.4. Results from the crude assay for the block containing the H254X and 
W131X single substitution libraries.  The block was screened with paraoxon (A) and 
DEVX (B) 
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 The block containing the single libraries H257X and Y309X was screened with 
paraoxon and DEVX.  The locations of all variants and controls are shown in Table 2.3. 
The paraoxon screen showed comparable rates of the variants H257W, H257Y, and 
Y309A relative to the wild type standard (Figure 2.5A). The kcat/Km (M-1s-1) values for 
H257W, H257Y, and Y309A are 4.4 x 107, 6.4 x 107, and 6.1 X 106, respectively (Chen-
Goodspeed et al., 2001a, 2001b).  Although the kcat/Km value for Y309A is 
approximately 10-fold lower than the wild type, that rate difference seems smaller on the 
crude cell assay. The 10-fold decrease in activity of the mutant H257A (kcat/Km = 3.4 x 
106) is also reflected in the paraoxon screen.  In the DEVX crude cell assay, two variants 
were higher than the QF standard (Figure 2.5B).  However, the activity of the controls in 
this plate with DEVX was lower in general than the rest of the plates. Both H257S and 
H257T were purified and the kinetic constants were determined to be lower than those 
for QF.   
Screening results for the growth block containing the single substitution libraries 
L303X and M317X are shown in Figure 2.6.  The positions of all variants relative to 
controls are shown in Table 2.4. The activity of the wild type and H254A standards with 
paraoxon was lower than expected. The kcat/Km value for paraoxon hydrolysis by the 
mutant L303A is 9.0 x 106 M-1s-1, which was reflected in approximately 10-fold lower 
activity on the crude assay compared to wild type. When screened with DEVX, the 
relative activity of the controls was reproducible.  H254A remained higher than wild 
type, but lower than H254Q/H257F.  The mutant L303F was slightly higher than wild 
type, but remained lower than the control H254Q/H257F.  
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Table 2.3. Positions of members of the H257X and Y309X single substitution libraries.  
Standards (in red) are wild type, H254A, H254Q/H257F (QF), I106A/F132A/H257Y 
(AAY), H254G/H257W/L303T (GWT), and BL21 cells. 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 
H257A 
9 
H257F 
17 
H257K 
25 
H257P 
33 
H257S 
41 
H257Y 
49 
Y309D 
57 
Y309H 
65 
Y309L 
73 
Y309Q 
81 
Y309T 
 
89 
B 2 
H257A 
10 
H257F 
18 
H257K 
26 
H257P 
34 
H257S 
42 
H257Y 
50 
Y309D 
58 
Y309H 
66 
Y309L 
74 
Y309Q 
82 
Y309T 
 
90 
C 3 
H257C 
11 
WT 
19 
H257L 
27 
H254A 
35 
H257T 
43 
QF 
51 
Y309E 
59 
AAY 
67 
Y309M 
75 
GWT 
83 
Y309V 
 
91 
BL21 
D 4 
H257C 
12 
H257G 
20 
H257L 
28 
H257Q 
36 
H257T 
44 
Y309A 
52 
Y309E 
60 
Y309I 
68 
Y309M 
76 
Y309R 
84 
Y309AV 
 
92 
E 5 
H257D 
13 
H257G 
21 
H257M 
29 
H257Q 
37 
H257V 
45 
Y309A 
53 
Y309F 
61 
Y309I 
69 
Y309N 
77 
Y309R 
85 
Y309W 
 
93 
F 6 
H257D 
14 
WT 
22 
H257M 
30 
H254A 
38 
H257V 
46 
QF 
54 
Y309F 
62 
AAY 
70 
Y309N 
78 
GWT 
86 
Y309W 
 
94 
BL21 
G 7 
H257E 
15 
H257I 
23 
H257N 
31 
H257R 
39 
H257W 
47 
Y309C 
55 
Y309G 
63 
Y309K 
71 
Y309P 
79 
Y309S 
 
87 95 
H 8 
H257E 
16 
H257I 
24 
H257N 
32 
H257R 
40 
H257W 
48 
Y309C 
56 
Y309G 
64 
Y309K 
72 
Y309P 
80 
H257S 
 
88 96 
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Figure 2.5. Results from the crude assay for the block containing the H257X and Y309X 
single substitution libraries.  The block was screened with 0.1 mM paraoxon (A) and 0.2 
mM DEVX (B)   
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Table 2.4. Positions of members of the L303X and M317X single substitution libraries.  
Standards (in red) are wild type, H254A, H254Q/H257F (QF), I106A/F132A/H257Y 
(AAY), H254G/H257W/L303T (GWT), and BL21 cells. 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 
L303A 
9 
L303F 
17 
L303I 
25 
L303P 
33 
L303S 
41 
L303Y 
49 
M317D 
57 
M317H 
65 
M317L 
73 
M317R 
81 
M317V 
 
89 
B 2 
L303A 
10 
L303F 
18 
L303I 
26 
L303P 
34 
L303S 
42 
L303Y 
50 
M317D 
58 
M317H 
66 
M317L 
74 
M317R 
82 
M317V 
 
90 
C 3 
L303C 
11 
WT 
19 
L303K 
27 
H2554A 
35 
L303T 
43 
QF 
51 
M317E 
59 
AAY 
67 
M317N 
75 
GWT 
83 
M317W 
 
91 
BL21 
D 4 
L303C 
12 
L303G 
20 
L303K 
28 
L303Q 
36 
L303T 
44 
M317A 
52 
M317E 
60 
M317I 
68 
M317N 
76 
M317S 
84 
M317W 
 
92 
E 5 
L303D 
13 
L303G 
21 
L303M 
29 
L303Q 
37 
L303V 
45 
M317A 
53 
M317F 
61 
M317I 
69 
M317P 
77 
M317S 
85 
M317Y 
 
93 
F 6 
L303D 
14 
WT 
22 
L303M 
30 
H254A 
38 
L303V 
46 
QF 
54 
M317F 
62 
AAY 
70 
M317P 
78 
GWT 
86 
M317Y 
 
94 
BL21 
G 7 
L303E 
15 
L303H 
23 
L303N 
31 
L303R 
39 
L303W 
47 
M317C 
55 
M317G 
63 
M317K 
71 
M317Q 
79 
M317T 
 
87 95 
H 8 
L303E 
16 
L303H 
24 
L303N 
32 
L303R 
40 
L303W 
48 
M317C 
56 
M317G 
64 
M317K 
72 
M317Q 
80 
M317T 
 
88 96 
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Figure 2.6. Results from the crude screen for the block containing the L303X and 
M317X single substitution libraries.  The block was screened with 0.1 mM paraoxon (A) 
and 0.2 mM DEVX (B).   
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 The block containing the F306X and L271X single substitution libraries was 
screened with paraoxon and DEVX as well.  Shown in Table 2.5 and Figure 2.7, are the 
distribution of all variants and results for the crude screen, respectively.  The activity of 
F306A, located in positions 1 and 2, was 34 mA400 min-1, which is 300-fold lower than 
wild type (Figure 2.7A).  This is consistent with the published kcat/Km value for purified 
F306A (2.3 x 105 M-1s-1), which is 280-fold lower than wild type (Chen-Goodspeed et 
al., 2001a, 2001b).  However, some inconsistency in the crude assay was observed.  For 
example, the activity of the variant L271A on the crude assay was 600 mA400min-1, 
which is 16-fold lower than wild type.  The purified L271A has a kcat/Km of 1.2 x 107 M-
1s-1, which is only 5-fold lower than wild type.  Also, no activity towards paraoxon 
hydrolysis was observed for the variants L271F and L271W, although the purified 
protein displayed a 2-fold decrease on kcat/Km compared to wild type.  Screening with 
the VX analog, DEVX, did not result in any enhancements over the control 
H254Q/H257F (Figure 2.7B).   
    
 
 
 
 
 
 
 
 54
Table 2.5. Positions of members of the F306X and L271X single substitution libraries.  
Standards (in red) are wild type, H254A, H254Q/H257F (QF), I106A/F132A/H257Y 
(AAY), H254G/H257W/L303T (GWT), and BL21 cells. 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 
F306A 
9 
F306G 
17 
F306K 
25 
F306P 
33 
F306S 
41 
F306Y 
49 
L271D 
57 
L271H 
65 
L271M 
73 
L271R 
81 
L271V 
 
89 
B 2 
F306A 
10 
F306G 
18 
F306K 
26 
F306P 
34 
F306S 
42 
F306Y 
50 
L271D 
58 
L271H 
66 
L271M 
74 
L271R 
82 
L271V 
 
90 
C 3 
F306C 
11 
WT 
19 
F306L 
27 
H254A 
35 
F306T 
43 
QF 
51 
L271E 
59 
AAY 
67 
L271N 
75 
GWT 
83 
L271W 
 
91 
BL21 
D 4 
F306C 
12 
F306H 
20 
F306L 
28 
F306Q 
36 
F306T 
44 
L271A 
52 
L271E 
60 
L271I 
68 
L271N 
76 
L271S 
84 
L271W 
 
92 
E 5 
F306D 
13 
F306H 
21 
F306M 
29 
F306Q 
37 
F306V 
45 
L271A 
53 
L271F 
61 
L271I 
69 
L271P 
77 
L271S 
85 
L271Y 
 
93 
F 6 
F306D 
14 
WT 
22 
F306M 
30 
H254A 
38 
F306V 
46 
QF 
54 
L271F 
62 
AAY 
70 
L271P 
78 
GWT 
86 
L271Y 
 
94 
BL21 
G 7 
F306E 
15 
F306I 
23 
F306N 
31 
F306R 
39 
F306W 
47 
L271C 
55 
L271G 
63 
L271K 
71 
L271Q 
79 
L271T 
 
87 95 
H 8 
F306E 
16 
F306I 
24 
F306N 
32 
F306R 
40 
F306W 
48 
L271C 
56 
L271G 
64 
L271K 
72 
L271Q 
80 
L271T 
 
88 96 
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Figure 2.7. Results from the crude screen for the block containing the F306X and L271X 
single substitution libraries.  The block was screened with 0.1 mM paraoxon (A) and 0.2 
mM DEVX (B). 
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 The sixth block contained the F132X and S308X single substitution libraries.  
The identities of all variants and results for the crude screen are shown in Table 2.6 and 
Figure 2.8, respectively.   The paraoxon screen revealed slight variations compared to 
rates obtained using purified protein.  For example, the published kcat/Km value for 
F132A is 3.4 x 107 M-1s-1, which is 2-fold lower than wild type (Chen-Goodspeed et al., 
2001a, 2001b).  However, the F132A variant on this plate was approximately 4-fold 
lower than wild type.  The activity of F132G, S308A, and S308A relative to wild type 
was in agreement with the kinetic parameters for the purified protein.  The relative 
activity towards DEVX hydrolysis for which the activity of H254A was greater than 
wild type, but less than H254Q/H257F was reproducible in this growth block (Figure 
2.8B).  The variants F132I, S308T, and S308K had a slightly higher activity compared to 
wild type, but were lower than QF.            
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Table 2.6. Positions of members of the F132X and S308X single substitution libraries.  
Standards (in red) are wild type, H254A, H254Q/H257F (QF), I106A/F132A/H257Y 
(AAY), H254G/H257W/L303T (GWT), and BL21 cells. 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 
F132A 
9 
F132G 
17 
F132K 
25 
F132P 
33 
F132S 
41 
F132Y 
49 
S308D 
57 
S308H 
65 
S308L 
73 
S308Q 
81 
S308V 
 
89 
B 2 
F132A 
10 
F132G 
18 
F132K 
26 
F132P 
34 
F132S 
42 
F132Y 
50 
S308D 
58 
S308H 
66 
S308L 
74 M317Q 82 
S308V 
 
90 
C 3 
F132C 
11 
WT 
19 
F132L 
27 
H254A 
35 
F132T 
43 
QF 
51 
S308E 
59 
AAY 
67 
S308M 
75 
GWT 
83 
S308W 
 
91 
BL21 
D 4 
F132C 
12 
F132H 
20 
F132L 
28 
F132Q 
36 
F132T 
44 
S308A 
52 
S308E 
60 
S308F 
68 
S308M 
76 
S308R 
84 
S308W 
 
92 
E 5 
F132D 
13 
F132H 
21 
F132M 
29 
F132Q 
37 
F132V 
45 
S308A 
53 
S308F 
61 
S308I 
69 
S308N 
77 
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85 
S308Y 
 
93 
F 6 
F132D 
14 
WT 
22 
F132M 
30 
H254A 
38 
F132V 
46 
QF 
54 
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70 
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78 
GWT 
86 
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94 
BL21 
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Figure 2.8. Results from the crude screen for the block containing the F132X and S308X 
single substitution libraries.  The block was screened with 0.1 mM paraoxon (A) and 0.2 
mM DEVX (B).  
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Screening of the Third Generation Libraries in the H254Q/H257F Template 
 Since H254Q/H257F (QF) displayed the most enhancement for DEVX 
hydrolysis compared to wild type, it was utilized as a parent for randomizing the 
remaining ten amino acid residues in the substrate binding pocket of PTE.  Due to the 
observed inconsistency in levels of protein expression associated with the pBS+ vector, 
the opd gene was expressed in the medium copy number expression vector, pZA32-Luc.  
Consequently, the construct pZA32-QF was utilized as a template for the third 
generation libraries.  Ten libraries were constructed; pZA32-QF/G60X, pZA32-
QF/I106X, pZA32-QF/L271X, pZA32-QF/Y309X, pZA32-QF/F306X, pZA32-
QF/W131X, pZA32-QF/F132X, pZA32-QF/L303X, pZA32-QF/M317X, and pZA32-
QF/S308X.  Four to six colony forming units (CFU’s ) were selected from each library 
and sequenced to confirm sample randomness (Table 2.7).  Two growth blocks were 
screened for each library.  The previously characterized standards, wild type and 
H254Q/H257F were included in positions 11 & 14 and 27 & 30, respectively.   
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Table 2.7. The identities of random colonies isolated from each single substitution 
library in the pZA32-QF template. 
QF/W131X QF/F132X QF/Y309X QF/G60X 
TGG wild type TTC wild type TAC wild type GGT wild type 
GAG Glu GGG Gly CTC Leu CTG Leu 
AGG Arg CTG Leu TCC Ser GGT Gly 
GCC Ala TAG Stop CAC His GGT Gly 
TAG stop ATC Ile TAC Tyr GCC Ala 
CCG Pro GGC Gly TTC Phe   
 
QF/F306X 
 
QF/I106X 
 
QF/L271X 
 
QF/L303X 
TTC wild type ATC wild type CTG wild type CTG wild type 
GGC Gly TCC Ser CTG Leu GTG Glu 
CAG Gln ATC Ile CTC Leu TCC Ser 
TTC Phe ACG Thr AAC Asn GTG Val 
GGC Gly TCG Ser AAG Lys GAC Asp 
CCG Pro GCA Ala GCG Ala CTG Leu 
CGC Arg TCC Ser     
    
QFS308X M317X     
AGC wild type ATG wild type     
CTC Leu TAC Tyr     
CAC His AGC Ser     
CCC Pro TAC Tyr     
AGC Ser       
CAG Gln       
.   
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 The pZA32-QF/Y309X library was screened with 0.1 mM paraoxon and 0.2 mM 
DEVX.  Figure 2.9A and B shows the DEVX screening results for block 1 and block 2, 
respectively.  Standards are shown in red.  Block 1 contained one copy of the wild type 
standard in position 14.  Four variants were isolated from that block and sequenced 
because they displayed similar activity to the QF control.  Sequencing results indicated 
that they are the template QF.  Screening results from block 2 are shown in Figure 2.9B.  
In this plate the variant QF/Y309L in well number 40 and 87 was slightly higher than the 
QF control, while QF/Y309E had similar rate.  In general, there were no significant 
enhancements towards DEVX hydrolysis compared to the controls.  
 Screening results for pZA32-QF/I106X are shown in Figure 2.10A and B.  In 
block 1, several variants displayed enhancements over wild type.  They were identified 
as QF/I106Q, QF/I106L, QF/I106S, and QF/I106P.  The template QF was represented in 
this block at approximately 4% of the total population.  Although the background was 
relatively high in block 2, the standard QF was easily distinguishable from the 
background.  
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Figure 2.9. Results from the crude screen for the pZA32-QF/Y309X library, block 1 (A) 
and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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Figure 2.10. Results from the crude screen for the pZA32-QF/I106X library, block 1 (A) 
and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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 Two growth blocks from the library pZA32-QF/L271X were similarly screened 
for the hydrolysis of the VX analog, DEVX (Figure 2.11A and B).  The activity of the 
standard QF was lower in this library compared to other blocks.  In block 1, the template 
QF was present at approximately 2% of the population.  Two different wild type codons 
were identified by DNA sequencing, which further confirms the randomness of the 
library. However, that did not seem to affect the overall activity. The variants 
QF/L271V, QF/L271M, and QF/L271I displayed relatively similar activity to the QF 
control. 
 The results obtained from screening the library pZA32-QF/F306X for hydrolysis 
of DEVX are presented in Figure 2.12A and B.  Similarly, the library pZA32-QF/F306X 
showed reasonable representation of the controls.  Both codons for phenylalanine were 
identified by DNA sequencing, which further ensures the randomness of the mutagenesis 
procedure.  However, no variants displayed higher rates for DEVX hydrolysis.  
 
 
 
 
 
 
 65
 
Figure 2.11. Results from the crude screen for the pZA32-QF/L271X library, block 1 
(A) and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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Figure 2.12. Results from the crude screen for the pZA32-QF/F306X library, block 1 (A) 
and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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 The results for screening two blocks from the library pZA32-QF/M317X are 
shown in Figure 2.13A and B.  The previously identified mutants; QF/M317Y and 
QF/M317S were inoculated in positions 1, 2 of block 1, respectively.  The order of 
activity of the standard H254Q/H257F relative to wild type was reproducible in this 
library as well.  In block 1, one variant had a 10-fold enhancement over wild type.  
However, DNA sequencing revealed that it was the template, H254Q/H257F.  This 
could be due to variations in protein expression within the library.  In block 2, the 
mutant QF/M317L was 2-fold higher than wild type, but remained lower than the QF 
standard.   
 In the same manner, the library pZA32-QF/S308 was screened for DEVX 
hydrolysis (Figure 2.14A and B).  The assay background was unusually higher in this 
library compared to other plates.  The previously sequenced CFU’s; QF/S308L, S308H, 
S308P, wild type, S308Q, S308E, and S308V were inoculated in positions 1, 2, 3, 4, 5, 
6, 7 of block 1, respectively.  Block 2 contained several mutants that were isolated and 
sequenced for having slightly elevated activity compared to the QF control.  They were 
identified as QF/S308A, QF/S308C, QF/308W, QF/S308N, and QF/S308K.   
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Figure 2.13. Results from the crude screen for the pZA32-QF/M317X library, block 1 
(A) and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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Figure 2.14. Results from the crude screen for the pZA32-QF/S308X library, block 1 (A) 
and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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 One block from the pZA32-QF/W131 library was screened due to the lower level 
of PCR amplification, which resulted in fewer colonies (Figure 2.15). The background 
for the DEVX assay was unusually high, and no variants could be isolated for enhanced 
activity. 
 Two blocks from the QF/F132X library were screened with paraoxon and DEVX 
(Figure 2.16A and B). The standards included in this library were wild type in positions 
11 & 14, H254A in positions 27 & 30, and QF in positions 43 & 46.  The variant 
QF/F132L isolated from both block 1 and block 2 had slightly higher rate for DEVX 
hydrolysis than the QF control.  Also, QF/F132I displayed the same level of activity as 
the standard QF. 
 Similarly, two blocks representing the pZA32-QF/G60X were screened for the 
hydrolysis of 0.2 mM DEVX.  (Figure 2.17A and B).  DNA sequencing of mutants 
selected from block 1 indicated that the background level caused by the QF parent was 
approximately 4-6% of the library.  The mutant QF-G60A displayed a small 
enhancement over wild type, but not the template.  The same mutation was isolated from 
block 2 in addition to the variant QF/G60T.  It is worth mentioning that the 
H254Q/H257F background was caused not only by the template, but also by the 
mutagenesis to other glycine codons.   
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Figure 2.15. Results from the crude screen for the pZA32-QF/W131X library.  The 
library was screened with 0.2 mM DEVX (4). 
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Figure 2.16. Results from the crude screen for the pZA32-QF/F132X library, block 1 (A) 
and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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Figure 2.17. Results from the crude screen for the pZA32-QF/G60X library, block 1 (A) 
and block 2 (B).  The library was screened with 0.2 mM DEVX (4). 
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 The final third generation library screened was the pZA32-QF/L303X library.  
Only one block was screened from this library because of low PCR product yield.  The 
previously identified mutants; QF/L303E, L303S, L303V, L303D, wild type are located 
in wells number 1, 2, 3, 4, and 5, respectively (Figure 2.18).  Screening this library for 
DEVX hydrolysis did not result in identifying variants with enhanced activity relative to 
the parent H254Q/H257F.    
 Several mutants were isolated from the crude assay and purified for they 
displayed enhanced activity over wild type towards the hydrolysis of the VX analog, 
DEVX.  The kinetic parameters are reported in Table 2.8.  In addition, a comparison of 
H254Q/H257F to other PTE mutants that have displayed improvements for the 
hydrolysis of p-nitrophenol analogs of the nerve agents sarin and soman is shown in 
Figure 2.19.  The assay conditions with regard to substrate concentration were similar to 
the crude assay, so that the rate observed is correlated to the kcat/Km values relative to 
wild type and QF.  The comparison of the rates reported in Figure 2.19 clearly show that 
H254Q/H257F has highest improvement for DEVX hydrolysis.  
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Figure 2.18. Results from the crude screen for the pZA32-QF/L303X library.  The 
library was screened with 0.2 mM DEVX (4). 
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Table 2.8. Kinetic parameters of selected PTE mutants for the hydrolysis of DEVX. 
Protein kcat (s-1) Km (mM) 
 
kcat/Km (M-1s-1) 
 
WT 0.8 (0.1) 0.8 (0.2) 10
3 (130) 
 
H254G 0.2 (0.004) 0.8 (0.05) 2.5 x 10
2 (10) 
 
H254R 0.4 (0.02) 3.5 (0.3) 120 (5)  
H254Q/H257F 7.4 (0.5) 2.6 (0.3) 3.0 x 10
3 (300) 
 
QF/I106P ND ND 2.8 x 10
2 (17) 
 
QF/I106Q 1.4 (0.04) 0.4 (0.05) 3.2 x 10
3 (250) 
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Figure 2.19. The specific activity (μmol min-1 mg-1) of purified PTE mutants for the 
hydrolysis of the VX analog, DEVX.  The assay contained 0.2 mM substrate, 0.3 mM 
DTNB, and 50 mM HEPES, pH 8.0.   
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 Several other libraries were screened for DEVX hydrolysis, but no beneficial 
mutations could be identified (data not shown).  Those libraries targeted primarily the 
substrate binding pocket of PTE.  They were H254A/H257X, H254R/H257X, 
H254R/Y309X, H254R/I106X, and H254R/F306X.     
 
Hydrolysis of the Pesticide Demeton-S 
 The H254Q /H257F mutant was tested for its ability to hydrolyze the pesticide 
demeton-S.  Table 2.9 shows a comparison of the kinetic parameters for demeton-S by 
wild type PTE and selected mutants.  QF displayed an 18-fold enhancement in the 
turnover number over wild type and a 10-fold enhancement in kcat/Km.  Another mutant 
that showed enhancement towards demeton-S hydrolysis, H254G/H257F, had 
phenylalanine at position 257.  H254Q/H257F was 2-fold less than the best characterized 
mutant for demeton-S hydrolysis, H254R/H257L.     
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Table 2.9. Kinetic parameters for the hydrolysis of demeton-S by wild type PTE and 
selected mutants.  
Protein kcat (s-1) Km (mM) kcat/Km (M-1s-1) 
 
WT 1.0 (0.002) 3.0 (0.2) 380 (25) 
 
H254A 2.4 (0.1) 4.3 (0.3) 560 (45) 
 
H254Ra 1.2 (0.03) 1.1 (0.1) 1.1 x 103 (100) 
 
H254Q/H257F 18 (0.65) 5.0 (0.4) 3.8 x 103 (400) 
 
H254R/H257Fa 7.5 (0.4) 2.3 (0.3) 3.3 x 103 (460) 
 
H254R/H257La 19 (0.4) 2.3 (0.1) 8.4 x 103 (400) 
 
a kinetic parameters were provided by Dr. Craig Hill (Unpublished data) 
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Discussion  
Targeting the VX Analog within the Double Substitution Library H254X/H257X 
 Previous studies have indicated that PTE is a potential candidate for the 
detoxification of organophosphates.  Engineering the substrate binding site of PTE has 
proven promising for altering the substrate specificity and enhancing the catalytic 
efficiency towards the hydrolysis of sarin and soman analogs (Li et al., 2001 and Hill et 
al., 2003).  Both His254 and His257 are located in the large subsite.  It has been 
demonstrated that beneficial mutations can be isolated by simultaneously randomizing 
His254 and His257.  The H254X/H257X double substitution library was screened in a 
search for mutants with enhanced activity towards the hydrolysis of the VX analog, 
DEVX.  The screen resulted in identifying the mutant H254Q/H257F with 
approximately 3-fold enhancement over wild type.  Another mutant was identified with a 
phenylalanine at position 257, H254G/H257F.  Comparison of kinetic parameters 
indicated that H254Q/H257F exhibited a 10-fold enhancement over wild type for kcat 
and a 3-fold enhancement in kcat/Km.   
 The mutant H254Q/H257F displayed enhancement over wild type when the 
block containing the G60X and I106X single substitution libraries was screened for 
hydrolysis of the SPRC/SPSC-(1) and the SPSC(1) analogs of the nerve agent soman 
(Scheme 2.4).  Purified QF exhibited a 100-fold enhancement in kcat/Km for hydrolysis 
of the SPRC-(1) and SPSC-(1) (Ph.D. dissertation by Karin T. Lum).     
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Scheme 2.4. Structures of the individual stereoisomers of the p-nitrophenol soman 
analog. 
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Phe132, Trp131, Ser308, and Tyr309.  The variants I106S and I106T/F132L were 
isolated for they exhibited 1.3-fold and 1.8-fold enhancement for paraoxon hydrolysis 
over the wild type.  No significant enhancements resulted from the single substitution 
libraries.  The H254C, H257S, H257T, and L303F mutants displayed slight 
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improvement over the wild type, but remained less active than the H254Q/H257F 
mutant.   
 
Targeting the VX Analog within the Third Generation Libraries in the QF Template 
 Ten amino acid residues within the PTE active site were randomized in the 
H254Q/H257F template in a search for improved variants for DEVX hydrolysis.  Most 
mutations in the pZA32-QF/Y309X appeared to be detrimental to DEVX hydrolysis.  
The QF/Y309E and QF/Y309L were identified in this library for having similar activity 
to the QF template.  There was a slight variation in the activity of the parent QF, which 
could be due to variations in protein expression.   
    Several variants were isolated from the pZA32-QF/I106X library for displaying a 
comparable activity to the standard QF.  They were identified as QF/I106S, QF/I106P, 
QF/I106Q, and QF/I106L.  Both QF/I106P and QF/I106Q were purified and the kinetic 
parameters for DEVX hydrolysis were determined.  While the kcat/Km value for 
QF/I106Q was very similar to QF, the kcat/Km for QF/I106P was 10-fold slower (Table 
2.8).   
 Like the PZA32-QF/Y309X library, the majority of mutations in the pZA32-
QF/L271X were detrimental.  Few mutations did not seem to reduce the rate of DEVX 
hydrolysis.  They were identified as L271M, L271V, and L271I.  Interestingly, one 
variant displayed a 10-fold increase in paraoxon hydrolysis over the parent, QF, which 
was identified as QF/L271G (data not shown).   
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 No improvements for the hydrolysis of DEVX resulted from screening the 
pZA32-QF/F306X and pZA32-QF/M317X libraries.  All variants isolated were 
identified as the parent QF except for the QF/M317L mutant, which had a similar 
activity as the standard QF.  Despite the high background obtained from screening the 
pZA32-QF-S308X for DEVX hydrolysis, several variants were isolated for they were as 
active as the template QF.  The isolated mutants had alanine, asparagine, valine, 
cysteine, or lysine at position 308.  This suggests that mutating Ser308 was not as 
detrimental to hydrolysis of DEVX compared to other resides.   
 No beneficial mutations for DEVX hydrolysis resulted from mutating Trp131 in 
the QF template. However, the QF/W131E mutant had a 4-fold enhancement in 
paraoxon hydrolysis over the template QF (data not shown).  Results from the F132X 
library constructed in the QF template have indicated that the vast majority of the 
mutations are detrimental to the activity against DEVX.  Two mutants were identified 
for having beneficial mutations, the QF/F132L and QF/133I mutants.  No enhancements 
over the standard QF were obtained from the G60X and the L303X libraries in the QF 
template.   
 Although the crude screen has shown some variations in the rates for paraoxon 
and DEVX hydrolysis, it was successful in the identification of variants with enhanced 
activity compared to wild type.  In most cases, the kinetic parameters of purified mutants 
were in agreement with the relative activity on the crude assay.  Attempts to further 
improve the catalytic efficiency of H254Q/H257F by constructing the third generation 
libraries did not result in any enhancements.  However, some possibilities have not been 
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explored yet.  One possibility is to employ the technique of DNA shuffling to recombine 
the beneficial mutants isolated from the crude screens.   
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CHAPTER III 
CHARACTERIZATION OF GLYCEROPHOSPHODIESTER 
PHOSPHODIESTERASE FROM E. AEROGENES: 
IN VIVO SELECTION UTILIZING ORGANOPHOSPHATES AS 
THE SOLE PHOSPHORUS SOURCE 
 
Introduction 
 Organophosphate diesters are utilized in biological systems as energy currency, 
signaling molecules, and components in cellular molecules such as nucleic acids and 
phospholipids.  Hence, organophosphate diesters are very abundant in organisms.  
Phosphodiesterases are involved in regulating a range of intracellular processes.  For 
example, cyclic AMP phosphodiesterases play a key role in regulating the intracellular 
level of the signal mediator cAMP. 
Glycerophosphodiester phosphodiesterase (GpdQ) from E. aerogenes is a part of 
an operon homologous to the glycerol-3-phosphate (G3P) uptake operon in E. coli (ugp) 
(Larson et al., 1983).  In E. aerogenes, expression of GpdQ is induced under phosphate 
limiting conditions.  GpdQ was previously purified and the amino acid composition was 
determined (Gerlt et al., 1975).  It is believed to be the first phosphohydrolase known to 
cleave alkyl diesters such as dimethyl phosphate (DMP) and diethyl phosphate (DEP).  
In addition, GpdQ catalyzes the hydrolysis of a broad range of phosphodiesters including 
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bis-p-nitrophenyl phosphate, gylcerophosphoethanolamine (GPE), ethylene phosphate, 
and cyclic AMP (Gerlt et al., 1975, and McLoughlin et al., 2004). 
 Multiple sequence alignment of GpdQ with glycerophosphodiester 
phosphodiesterases from E. coli, and T. maritima, shows low sequence homology (10%).  
Sequence analysis suggests that GpdQ is a member of class III 3’, 5’-cyclic nucleotide 
phosphodiesterases (PDE’s) along with E. coli 3’, 5’-cAMP phosphodiesterase, Ser/Thr 
protein phosphatases, and purple acid phosphatases (Richter, 2002).  Members of this 
family contain a binuclear metal center in their active site and share the conserved 
sequence motif, DXH(X)nGDXXD(X)nGNHD/E, that forms the metal ion binding site 
(Figure 3.1). 
 Ollis and co-workers demonstrated that GpdQ enables E. coli to utilize alkyl 
phosphodiesters (e.g. DMP and DEP) as the sole phosphorus source (McLoughlin et al., 
2004).  An in vivo growth assay where GpdQ was co-expressed with organophosphorus 
hydrolase from Agrobacterium radiobacter (opdA) (Horne, et al., 2002) was employed 
to examine the ability of E. coli to break down dimethyl-p-nitrophenyl phosphate 
(methyl paraoxon) to inorganic phosphate (Scheme 3.1).  Their findings showed that, 
under phosphate limiting conditions, cells expressing only opdA were unable to utilize 
the phosphotriester as a source of phosphate.  However, cells co-expressing GpdQ and 
opdA, with the triesterase being the growth limiting factor, allowed E. coli to grow on 
methyl paraoxon as the sole phosphorus source.   
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Scheme 3.1. Proposed catabolic pathway of methyl paraoxon.  
 
 In this chapter, a more detailed characterization of GpdQ with regard to substrate 
specificity is presented.  A series of organophosphate diesters and methyl phosphonate 
monoesters were exploited as potential substrates.  The aim of this investigation was to 
expand the application of the in vivo coupling assay to cover a number of  analogs of the 
chemical warfare agents; GF, sarin, soman, VX, and Russian VX.  In the case of methyl 
phosphonate monoesters, the released methyl phosphonate is degraded by the gene 
products of the Phn operon (Wanner, 1994).  The Phn operon is only induced under 
phosphate starvation conditions and is known to enable E. coli to utilize methyl 
phosphonate as a phosphorus source.  This would provide an alternative means to 
conventional screening assays in the search for improved variants of PTE for the 
detoxification of organophosphate triesters.  
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Figure 3.1. Multiple sequence alignment of the P. syringae Ser/Thr protein phosphatase, 
P. syringae metallophosphatase, E. aerogenes GpdQ, and E. coli 3’,5’- cAMP 
phosphodiesterase.  Residues involved in the metal ion-binding site are shaded in grey.   
 
Ser/Thr_phosphatase_P. syringae    ----------MNRPFLIAQISDLHLKADGRLTYGVVDTLGALRRAVAHIN 
Metallophosphoesterase_P. syringae ----------MNRPFLIAQISDLHLKADGRLTYGVVDTLGALRRAVAHIN 
GpdQ_E. aerogenes                  --------------MLLAHISDTHFRSRGEKLYGFIDVNAANADVVSQLN 
3’, 5’ cAMP_E. coli                MESLLTLPLAGEARVRILQITDTHLFAQKHEALLGVNTWESYQAVLEAIR 
                                                        * *  
 
Ser/Thr_phosphatase_P. syringae    ASKQRPDIVVISGDLVDFGREDEYAVLKPELERLQMPFYLVPGNHDDREN 
Metallophosphoesterase_P. syringae ASKQRPDIVVISGDLVDFGREDEYAVLKPELERLQMPFYLVPGNHDDRHN 
GpdQ_E. aerogenes                  ALRERPDAVVVSGDIVNCGRPEEYQVARQILGSLNYPLYLIPGNHDDKAL 
3’, 5’ cAMP_E. coli                PHQHEFDLIVATGDLAQDQSSAAYQHFAEGIASFRAPCVWLPGNHDFQPA 
                                         *  *  **         *            *    *****    
 
Ser/Thr_phosphatase_P. syringae    LLAAFADQVYLPLAASGPLDWVVEQYPLRLIGMDTTIPGEHGGRLDYCQL 
Metallophosphoesterase_P. syringae LLAAFAEQVYLPLSASGPLDWVVEKYPVRLIGMDTTIPGEHGGQLDYCQL 
GpdQ_E. aerogenes                  FLEYLQPLCPQLGSDANNMRCAVDDFATRLLFIDSSRAGTSKGWLTDETI 
3’, 5’ cAMP_E. coli                MYSALQDAG------ISPAKRVFIGEQWQILLLDSQVFGVPHGELSEFQL 
                                                                    *    *   * *     
 
Ser/Thr_phosphatase_P. syringae    DWLNAQLSRRPDVPTVIVLHHPPFITGIGHMDREPFGNASALERVIAQHP 
Metallophosphoesterase_P. syringae DWLHAQLSRRPYVPTVIVMHHPPFITGIGHMDREPFGNASALERVIAQHP 
GpdQ_E. aerogenes                  SWLEAQLFEGGDKPATIFMHHPPLPLGNAQMDPIACENGHRLLALVERFP 
3’, 5’ cAMP_E. coli                EWLERKLADAPERHTLLLLHHHPLPAGCSWLDQHSLRNAGELDTVLAKFP 
                                    **   *            ** *   *    *     *   *       * 
 
Ser/Thr_phosphatase_P. syringae    QVERLLCGHLHRPMQRRFGGSVASICPGTSHQIVLDLDEAAPAHFNLEPA 
Metallophosphoesterase_P. syringae QVERLLCGHLHRPMQRRFGGSLASICPGTSHQIVLDLDEAAPAHFNLEPA 
GpdQ_E. aerogenes                  SLTRIFCGHNHSLTMTQYRQALISTLPGTVHQVPYCHEDTRP-YYDLSPA 
3’, 5’ cAMP_E. coli                HVKYLLCGHIHQELDLDWNGRRLLATPSTCVQFKPHCSNFT---LDTIAP 
                                         *** *               * *  *            
 
Ser/Thr_phosphatase_P. syringae    GYVLHRWDPEQGLVSHNAVFGDYEGPYPFYDEGGLID--- 
Metallophosphoesterase_P. syringae GYVLHRWQSEQGFVSHNAVFGDYEGPYPFYDVNGLID--- 
GpdQ_E. aerogenes                  SCLMHRQVGEQ-WVSYQHSLAHYAGPWLYDENISCPTEER 
3’, 5’ cAMP_E. coli                GWRTLELHADGTLTTEVHRLADTR----FQPDTASEGY-- 
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Materials and Methods 
Materials 
 Plasmids and strains used in this study are listed in Table 3.1.  E. aerogenes was 
purchased from ATCC (ATCC number 13048).  E. coli BL21-DEIII and XL1-blue cells 
were obtained from Stratagene.  The expression plasmid pET30 (a) and Platinium pfx 
DNA polymerase were purchased from Invitrogen.  The Genomic DNA purification kit 
was obtained from Promega.  Alcohol dehydrogenase and NAD+ were purchased from 
Sigma.  Organophosphate diesters and methyl phosphonates (Scheme 3.2) were 
synthesized in our laboratory by Dr. Yingchun Li and Dr. Chengfu Xu.  The medium 
copy number expression vector, pZA32-luc was generously provided by Dr. Ryland 
Young, Department of Biochemistry and Biophysics.  The overexpressing PTE 
construct, pET20b-5S was a gift from Dr. Dan Tawfik, Department of Biological 
Chemistry, Weizmann Institute of Science.  DNA sequencing was performed in the 
GTL, Texas A&M University 
 
Cloning of GpdQ     
 Genomic DNA from E. aerogenes was isolated using the Genomic DNA kit 
purchased from Promega, and used as the template for PCR amplification. The GpdQ 
gene was amplified by PCR using the primers, GpdQ (+) 5’- GGC GGC CAA GCT 
TGC AGG TTT AAA ATC ATA TGC TGT TAG CGC ACA TTT CCG ATA C and 
GpdQ (-)3’- CTA CGA ATT CTC ATC ATC ATT AGC GCT CTT CCG TTG GAC.  
The NdeI and EcoRI restriction sites are underlined.   PCR conditions were 95 °C for 30 
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seconds, followed by 30 cycles of 95 °C for 1 min, 55 °C for 1 min, 68°C for 4 min. and 
final extension at 68°C for 10 min.  The 824 bp PCR product was purified, digested with  
NdeI and EcoR I, and ligated in a similarly digested pET 30 (a). The ligation product 
was transformed in E. coli XL1-blue electro-competent cells for DNA sequencing.   
 
Scheme 3.2. Structures of the organophosphate diesters and methyl phosphonate 
monoesters used to investigate the substrate specificity of GpdQ. 
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Table 3.1. Description of plasmids and strains utilized in this work. 
Plasmid/Strain Description Reference 
pZA32-luc A medium copy number tac promoter 
expression vector 
Obtained from  
Dr. Young 
pZA32-opd Wild type PTE cloned in pZA32-luc plasmid  
GpdQ E. aerogenes phosphodiesterase cloned in 
pET30 (a) 
 
GpdQ+ GpdQ transformed in BL21-DEIII competent 
cells 
 
GpdQ/PTE GpdQ+ cells transformed with the plasmid 
pZA32-opd 
 
GpdQ/pET20b-5S GpdQ+ cells transformed with the pET20b-5S 
(overexpressing PTE construct) 
Roodveldt et al., 
2005 
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Purification of GpdQ  
 The plasmid pET30 encoding the GpdQ gene was transformed in BL21-DEIII 
electro-competent cells. Cells were grown in Luria-Bertani medium supplemented with 
0.05 mg/mL kanamycin and 1 mM MnCl2 at 30 °C until the OD600 reached 0.6.  Protein 
expression was induced by the addition of 1.0 mM isopropyl-β-thiogalactoside (IPTG) 
and the culture was grown for an additional 12 hours at 30 °C.  Cells were harvested by 
centrifugation and resuspended in 20 mM Tris-HCl buffer, pH 7.6, containing 0.1 
mg/mL phenylmethanesulfonyl fluoride (PMSF).  All purification steps were carried out 
at 4 °C.  Cells were disrupted by sonication, and the soluble fraction was isolated by 
centrifugation. The supernatant was treated with 1.5% protamine sulfate to precipitate 
nucleic acids. Protein was then precipitated with 60% saturation of ammonium sulfate. 
The ammonium sulfate pellet was resuspended in 20 mM Tris, pH 7.6 and loaded on a 
Superdex 200 gel filtration column (Amersham Biosciences).  Fractions eluted from the 
Superdex column were assayed for the hydrolysis of 1.0 mM bis-pNPP at pH 9.0.  
Fractions with the highest activity were pooled and loaded on a Resource Q anion 
exchange column (Amersham Biosciences) and eluted with 0-1M sodium chloride 
gradient in 20 mM Tris-HCl buffer, pH 7.6.  SDS-PAGE indicated that the protein was 
at least 95% pure and that the activity was associated with a band at ~ 31 kDa.  Protein 
concentration was determined using ε280 = 38,600 M-1cm-1.  The purified protein was 
dialyzed against 10 mM HEPES pH 7.6 and concentrated to 10 mg/mL for 
crystallography purposes.  
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Kinetic Measurements and Data Analysis 
All kinetic measurements ware performed on a SPECTRAmax-340 plate reader 
(Molecular Devices Inc, Sunnyvale CA).  The assays contained 0.1 mM MnCl2 and 25 
mM CHES buffer, pH 9.0.  The release of p-nitrophenol (ε400 = 17,000 M-1cm-1) was 
monitored at 25 °C for the enzymatic hydrolysis of compounds 1-7.  Hydrolysis of 
diethyl phosphate, dimethyl phosphate, O-ethyl methyl phosphonate, and O-isopropyl 
methyl phosphonate (8, 9, 10, and 11) was monitored by coupling the reaction to yeast 
alcohol dehydrogenase (YADH).  The assay contained 10 units ADH, 1.0 mM NAD+, 25 
mM CHES, pH 9.0, and 0.1 mM MnCl2.  The production of NADH (ε = 6.22 mM-1cm-1) 
was monitored at 340 nm.  Hydrolysis of O-isobutyl methyl phosphonate, O-cyclohexyl 
methyl phosphonate, and soman analog (12, 13, and 14) was monitored by coupling the 
reaction to liver alcohol dehydrogenase (LADH).  The assay contained 5 units ADH, 4.0 
mM NAD+, 25 mM CHES pH 9.0, and 0.1 mM MnCl2.  Hydrolysis of diethyl 
phosphate, O-ethyl methyl phosphonate, O-isopropyl methyl phosphonate and O-
isobutyl methyl phosphonate was also measured by NMR.  Methyl-demeton-S and 
DEVX (Scheme 3.3) hydrolysis was monitored using Ellman’s reagent, 5,5’-dithio-
bis(2-nitrobenzoic acid) (DTNB).  Release of the 2-nitro-5-thiobenzoate anion (ε412 = 
14,150 M-1cm-1) was followed at pH 8.0.  MnCl2 was included in the assay in a final 
concentration of 0.1 mM.  Total concentration of substrate was determined using the 
PTE mutant H254Q/H257F.  
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Scheme 3.3. Structure of DEVX and methyl-demeton-S. 
 
Kinetic parameters were obtained by fitting the data to equation 1 where v is the 
initial velocity, Vmax is the maximal velocity, S is substrate concentration, and Km is the 
Michaelis constant.  Relative concentrations of the substrate and the product were 
calculated by integrating the NMR spectra.  Rate constants for product formation and 
substrate decay were obtained by fitting the integration data to equations 2 and 3 
respectively.  In equations 2 and 3, y0 is the y-intercept, a is the amplitude, b is the rate 
constant, and t is the time.  Time course ratios for the GpdQ catalyzed hydrolysis of 
methyl demeton-s and DEVX were determined by fitting the data to equation 4, where y0 
is the y-intercept, a and c are the amplitudes of the curve, b and d are the rate constants.  
  v = Vmax [S]/Km + [S]                                                            (1) 
 y=y0 + a(1-e-bt)                                                                      (2) 
  y=y0 + a(e-bt)                                                                          (3) 
  y=y0 + a(1-e-bt) + c(1-e-dt)                                                     (4) 
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In Vivo Growth  Assays 
  E. coli BL21-DEIII competent cells were transformed with the GpdQ plasmid 
and plated on LB plates containing 0.05 mg/mL kanamycin resulting in GpdQ+ cells.  
Overnight cultures in LB media were inoculated from fresh transformations and washed 
three times with minimal media to remove any traces of rich medium.  To test the ability 
of GpdQ+ cells grow to on organophosphate diesters and organophosphonates, the 
growth rate was measured under phosphate limiting conditions using liquid 1X MOPS 
phosphate free minimal medium, pH 7.4 (Neidhardt et al., 1974).  The minimal medium 
was supplemented with 0.5 mM MnCl2, 0.1 % glucose as carbon source and 0.1 μg/mL 
thiamin (vitamin B1).  Cells were grown in the presence of 1.0 mM K2HPO4, 1.0 mM 
methyl phosphonate, 1.0 mM diethyl phosphate, 1.0 mM O-isopropyl methyl 
phosphonate, 1.0 mM O-isobutyl methyl phosphonate or 1.0 mM methyl phosphonate of 
soman analog.  A 20 mL culture was inoculated with 1% fresh, previously washed 
overnight culture.  As a control, GpdQ- BL21-DEIII cells were grown in the presence 
and absence of inorganic phosphate.  Cell growth was monitored by measuring the 
OD600 for 4-5 days at 30 °C. 
 The choice of organophosphate triester substrates for the in vivo selection under 
phosphate limiting condition is limited to the ability of E. coli to survive the release of a 
phenol leaving group upon hydrolysis.  Therefore, E. coli BL21-DEIII was tested for its 
ability to grow in the presence of various phenols (Scheme 3.4).  Cells were grown in 
LB medium containing 1.0 mM of each phenol.  Methanol was added to a final 
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concentration of 1.0% to enhance the solubility of some phenols.  Growth rate was 
monitored every 20 min at 37 °C for 24 hours. 
 
  
Scheme 3.4. Structures of various phenols tested for their effect on the growth of E. coli. 
 
 Cells co-expressing PTE and GpdQ were tested for their ability to grow on the 
paraoxon and Russian-VX analogs (Scheme 3.5) as the sole phosphorus source.  
Phosphate free MOPS minimal medium was supplemented with 1.0 mM of the triester, 
0.1 % glucose and 0.1 μg/mL thiamin.  A 20 mL culture was inoculated with 5% (v/v) 
from the overnight culture.  Additional metal was found to have an inhibitory effect in 
this case. 
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Scheme 3.5. Chemical structures of the organophosphate triesters used to test the in vivo 
selection under phosphate limiting conditions. 
 
Results 
Expression and Purification of Glycerophosphodiester Diesterase (GpdQ) 
 GpdQ was cloned from genomic DNA of E. aerogenes into the pET30 plasmid 
and expressed in E. coli BL21-DEIII.  GpdQ was purified using size exclusion and anion 
exchange column chromatography.  The overall yield obtained from a 1 liter culture was 
approximately 30-40 mg of purified protein (Table 3.2).  The diesterase activity is 
associated with ~ 31 kDa band on SDS-PAGE.  GpdQ elutes from an equilibrated 
Superdex gel filtration column at a volume equivalent to a molecular weight of 200 kDa.  
This suggests that the protein is a hexamer.  Specific activity of GpdQ towards the 
hydrolysis of 1.0 mM bis-pNPP was enhanced 2-fold and 4-fold when the assay included 
0.1 mM ZnCl2 and MnCl2, respectively.  Atomic absorption analysis of the purified 
protein indicated that GpdQ contains 1.0 equivalents of Mn2+ and 0.6 equivalents of 
Zn2+.   
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Table 3.2. Summary of the purification steps of GpdQ from E. aerogenes. 
Purification 
step 
Volume 
(mL) 
Protein 
(mg/mL)
Activity 
(unit/mL) 
Total 
mg 
Total 
units 
Specific activity 
(u/mg) 
Cell lysis 
 
30 110 113 3,300 3,400 1.3 
Protamine 
sulfate 
 
33 22 82 730 2,700 3.7 
(NH4)2SO4 
pellet 
 
12 32 270 384 3,200 8.4 
(NH4)2SO4 
supernatant 
 
31 6.0 0.8 186 5.0 0.1 
Superdex 200  
 
100 2.0 17.0 200 1,700 8.5 
 
 
Resource Q  
 
65 1.2 10.5 78 715 8.8 
 
 
2nd Superdex 
200  
30 1.3 12 39 360 9.2 
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Substrate Specificity of GpdQ 
   The substrate specificity of GpdQ towards the hydrolysis of various 
organophosphate diesters and organophosphonates was investigated using compounds 
listed in Scheme 3.2.  This list of potential substrates included analogs of chemical 
warfare agents for which the corresponding triester is a substrate for PTE.  For example, 
compounds 10, 11, 12, 13, and 14 are potential analogs of the nerve agents VX, sarin, 
RVX, soman and GF, respectively.   The kinetic parameters of compounds 1-7 were 
determined by monitoring the production of p-nitrophenol at pH 9.0.  Hydrolysis of 
compounds 8-14 was monitored by coupling the reaction to alcohol dehydrogenase and 
monitoring the production of NADH at pH 9.0.   
 Kinetic parameters are summarized in Table 3.3.  The best substrate for GpdQ 
was bis-p-nitrophenyl phosphate (1) with a kcat/Km value of 6.7 x 103 M-1s-1.  The 
substrate specificity of GpdQ followed two major trends.  Organophosphate diesters are 
better substrates than their corresponding phosphonates.  For example, the kcat/Km for the 
hydrolysis of O-ethyl-p-NPP (2) is 2-fold higher than the corresponding ethyl-pNPP (3).  
This feature was more pronounced in the case of O-phenyl-pNPP (6) where the catalytic 
efficiency was 10-fold higher than phenyl-pNPP (7).  The second feature that emerged 
from the substrate specificity profile is that the turnover number for organophosphate 
diesters with a p-nitrophenol leaving group is significantly higher than the turnover 
number for the corresponding aliphatic diester.  However, the Km values are lower for 
alkyl diesters.  For example, the kcat/Km for the hydrolysis of O-ethyl-p-NPP (2) is 400-
fold higher than the kcat/Km value for diethyl phosphate (9). 
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 Nuclear magnetic resonance (NMR) was employed to monitor the hydrolysis of 
four GpdQ substrates—diethyl phosphate, O-isobutyl methyl phosphonate, O-isopropyl 
methyl phosphonate, and O-ethyl methyl phosphonate (9, 10, 11, 12).  In the O-
isopropyl methyl phosphonate reaction, the concentration of GpdQ was 54 μM.  The 
decrease in the signal intensity at 25.9 ppm was accompanied by an increase in the 
methyl phosphonate signal at 20.9 ppm.  The NMR spectra for the reaction time course 
are shown in Figure 3.2A.  The area under both resonances was integrated and the 
product/substrate ratio was plotted against time to obtain the second order rate constant 
kcat/Km (Figure 3.2B).  The kcat/Km value was calculated as 0.83 ± 0.03 M-1s-1.  Similarly, 
the reduction of the O-isobutyl methyl phosphonate signal at 27.1 ppm was accompanied 
by an increase in the methyl phosphonate signal intensity at 21.2 ppm.  The 
concentration of GpdQ was 9.3 μM and the kcat value was calculated as 0.22 ± 0.008 s-1 
(Figure 3.3A and B). The rates obtained from the NMR assay are in agreement with the 
rates obtained using the alcohol dehydrogenase coupling assay.    
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Table 3.3. Kinetic parameters for the hydrolysis of organophosphate diesters and methyl 
phosphonate monoesters by GpdQ. 
 
 
 
Substrate kcat (s-1) Km (mM) kcat/Km (M-1s-1) 
1 6.0 (0.2) 0.9 (0.11) 6.7 x 103 (500) 
2 2.0 (0.05) 0.9 (0.08) 2.1 x 103 (102) 
3 0.5 (0.006) 0.4 (0.03) 1.2 x 103 (92) 
4 1.6 (0.04) 1.3 (0.1) 1.2 x 103 (74)  
5 1.0 (0.04) 6.5 (0.5) 169 (15) 
6 4.0 (0.1) 1.8 (0.1) 2.2 x 103 (178) 
7 2.8 (0.29) 13 (2.1) 215 (42) 
8 5.0 x 10-4 (1.2 x 10-5) 0.006 (0.001) 82 (14) 
9 1.0 x 10-3 (5.0 x 10-5) 0.2 (0.04) 5.0 (1.0) 
10 ND ND 2.2 (0.15) 
11 0.01 (7 x 10-4) 19.0 (2.1) 0.51 (0.02) 
12 0.1 (6 x 10-3) 3.3 (0.56) 33 (4.3) 
13 ND ND ND 
14 0.3 (0.02) 27 (3.0) 11 (0.54) 
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Figure 3.2. GpdQ-catalyzed hydrolysis of O-isopropyl methyl phosphonate (10 mM) 
monitored by NMR (A).  The amount of protein used was 54 μM and kcat/Km was 
calculated as 0.83 ± 0.03 M-1s-1 (B). 
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Figure 3.3. GpdQ-catalyzed hydrolysis of O-isobutyl methyl phosphonate (10 mM) 
monitored by NMR (A).  The amount of protein used was 9.3 μM and the turnover 
number was calculated as 0.22 s-1 ± 0.008 (B). 
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 In a similar experiment, the enzymatic hydrolysis of diethyl phosphate (10) was 
also monitored by NMR.  The reaction mixture contained 10 mM substrate and 73 μM 
enzyme.  The turnover number obtained for diethyl phosphate (9) hydrolysis is 0.015 ± 
0.002 s-1 (Figure 3.4A).  GpdQ catalyzed hydrolysis of O-ethyl methyl phosphonate (10) 
was monitored by NMR using 45 μM enzyme.  The kcat/Km value for substrate decay 
over time was calculated as 2.2 ± 0.25 M-1s-1 (Figure 3.4B).   
 GpdQ did not exhibit any measurable activity for the soman analog monoester 
(14).  Based on NMR spectra, less than 10% of the substrate was hydrolyzed after five-
day incubation with 48 μM enzyme.  This was further confirmed by the alcohol 
dehydrogenase coupling assay.   
 
Hydrolysis of Organophosphate Triesters 
 It has been previously reported that GpdQ has the ability to hydrolyze 
organophosphate triesters such as methyl paraoxon and methyl demeton-S (McLoughlin 
et al., 2004).  Figure 3.5A shows the time course for the hydrolysis of paraoxon by 77 
μM GpdQ.  The total concentration of paraoxon (20 μM) was determined using KOH 
hydrolysis and the turnover number was calculated as 8.7 x 10-6 s-1.  This is 
approximately 105-fold lower than the rate obtained for the corresponding diester, O-
ethyl-p-nitrophenyl phosphate.   
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Figure 3.4. Hydrolysis of 10 mM DEP using 73 μM GpdQ (A) and 10 mM O-ethyl 
methyl phosphonate using 45 μM GpdQ (B).  
 
Time (min)
0 100 200 300 400 500 600
pr
od
uc
t/s
ub
st
ra
te
0
20
40
60
80
100
A 
B 
Time (min)
0 100 200 300 400 500 600
%
 s
ub
st
ra
te
0
20
40
60
80
100
120
 106
GpdQ was further tested for its ability to hydrolyze a racemic mixture of O-methyl-O-
ethyl-p-nitrophenyl phosphate (Figure 3.5B).  The turnover number obtained for this 
compound is 6.8 x 10-5 s-1, which is 10-fold higher than kcat value for paraoxon 
hydrolysis.   The initial fast phase shown in Figure 3.5B could be due to a diester 
contaminant in the racemic mixture. 
 
Hydrolysis of Organophosphate Monoesters 
 In comparison to the rates obtained for the hydrolysis of organophosphate 
diesters, the activity of GpdQ toward the hydrolysis of 28 μM p-nitrophenyl phosphate 
was measured using 11 μM enzyme.  The turnover number was 1.3x 10-4 s-1, which is 
105-fold lower than the turnover number for the corresponding diester. This is consistent 
with the previously reported activity profile of GpdQ (Gerlt et al., 1975).   
 
Hydrolysis of Methyl-demeton-S and DEVX 
 GpdQ catalyzed hydrolysis of methyl-demeton-s was monitored using NMR and 
the spectrophotometeric Ellman assay.  Figure 3.6A shows the NMR spectra of 10 mM 
methyl-demeton-s incubated with 52 μM GpdQ and 10 mM DTNB at pH 8.0.  At time 
zero there is one major resonance at 35.2 ppm that corresponds to the substrate.  The 
substrate resonance was diminishing as a second resonance at 4.7 ppm was increasing.  
Integration of the area under both resonances indicated that after 7.5 hours, 30% of the 
substrate was hydrolyzed.   
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Figure 3.5. Hydrolysis of organophosphate triesters by GpdQ. (A)Time course for 
GpdQ-catalyzed hydrolysis of paraoxon.  The total concentration of paraoxon (20 uM) 
was determined using KOH.  The enzyme concentration was 77 μM and the turnover 
number was calculated as 8.7x 10-6 s-1.  (B) Hydrolysis of 40 μM racemic mixture of O-
methyl, O-ethyl-pNPP using 13 μM GpdQ.  The kcat was calculated as 6.8x 10-5 s-1. 
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 In a parallel experiment, the GpdQ catalyzed hydrolysis of methyl-demeton-S 
was monitored spectrophotometrically using the DTNB coupling assay.  Figure 3.6B 
shows the time course for the hydrolysis of 36 μM methyl-demeton using 23 μM GpdQ.  
A fit of the data to equation 4 provides two first order rate constants.  The observed rate 
constant for the initial fast phase was 0.002 (1.0 x 10-5) s-1 with an amplitude of 0.128 
(3.0 x 10-4).  Dividing the observed rate constant by the enzyme concentration yields a 
kcat/Km value of 89 M-1s-1.  The observed rate constant for the second phase was 0.0002 
(2.2 x 10-6) s-1 with an amplitude of 0.08 (2.0 x 10-4).  This provides a kcat/Km value of 
9.0 M-1s-1.  Based on the final absorbance determined by the PTE mutant H254Q/H257F, 
the reaction was approximately 50% completed.  Figure 3.7 shows the hydrolysis of 36 
μM methyl-demeton using 25 μM GpdQ presented in terms of concentration of product 
released.  After 60 minutes, an additional 25 μM enzyme was added, which drove the 
reaction to completion.  It appears that the enzyme is inhibited after a single turnover of 
the substrate.   
 A similar inhibitory effect was observed for DEVX hydrolysis.  Shown in Figure 
3.8, is the time course for the hydrolysis of 29 μM DEVX using 16 μM GpdQ.  A fit of 
the time course to equation 4 provided two first order rate constants; 0.0027 (7.2 x 10-6) 
s-1 and 0.0004 (2.3 x 10-6) s-1 with an amplitude of 0.154 and 0.04, respectively.  This 
corresponds to kcat/Km values of 169 M-1s-1 and 25 M-1s-1 for the fast and slow phase, 
respectively.     
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Figure 3.6. Hydrolysis of methyl-demeton-S by GpdQ. (A) NMR spectra for the 
hydrolysis of methyl-demeton-S by GpdQ.  (B) time course for the DTNB coupling 
assay. Concentration of GpdQ was 23 μM and the rates calculated as 89 M-1s-1 and 9 M-
1s-1 resulting in 10-fold difference.  
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Figure 3.7. Hydrolysis of 36 μM methyl-demeton-S presented in terms of concentration 
of product released.  GpdQ concentration was 25 μM.  
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Figure 3.8. GpdQ-catalyzed hydrolysis of DEVX.  The amount of enzyme used was 16 
μM.  The rates were caluculated as 169 M-1s-1 and 25 M-1s-1 resulting in 7-fold 
difference.   
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Growth of GpdQ+ Cells on Organophosphates/phosphonates  
 Cells expressing GpdQ were tested for their ability to grow on several 
organophosphate diesters and organophosphonate monoesters under inorganic phosphate 
limiting conditions.  Substrates tested were diethyl phosphate, O-isopropyl methyl 
phosphonate, O-isobutyl methyl phosphonate, and the soman analog (9, 11, 12, 13, and 
14 in Scheme 2).  Figures 3.9 and 3.10 show a graphical representation of the growth of 
GpdQ- and GpdQ+ cells in the presence of 1.0 mM substrate. As positive and negative 
controls, GpdQ- and GpdQ+ cells were grown in the presence and absence of 1.0 mM 
potassium phosphate, respectively.   E. coli cells lacking the diesterase gene were unable 
to utilize any of the substrates as a source of phosphorus, and were able to grow only 
when the minimal medium was supplemented with inorganic phosphate or methyl 
phosphonate. The methyl phosphonate time course was obtained on a different day using 
the same number of cells to inoculate the 20 mL culture.  On the other hand, GpdQ+ 
cells were able to grow on three of the four substrates tested.  As anticipated, growth rate 
was proportionally related to the catalytic efficiency of GpdQ towards each substrate.  
For example, cells growing on O-isopropyl methyl phosphonate as the phosphorus 
source experienced a lag time of nearly three days, which corresponds to the kcat/Km 
value of 0.5 M-1s-1.  In contrast, cells growing on O-isobutyl methyl phosphonate 
displayed a lag phase of approximately 30 hours corresponding to a kcat/Km value of 33 
M-1s-1.  Unsurprisingly, the soman analog did not support the growth of GpdQ+ cells 
which is consistent with the results obtained from the in vitro assays.  
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Figure 3.9. Growth of BL21–DEIII (GpdQ-) cells in the presence of organophosphates 
as the sole phosphorus source. Substrates that were tested included: inorganic phosphate 
(●), diethyl phosphate 9 (●), isoproyl methyl phophonate 11 (●), isobuty methyl 
phosphonate 12 (●), mono-ester of soman analog 13 (●), methyl phosphonate (●) and no 
phosphate source (●). Substrate concentration was 1.0 mM in 1X phosphate free MOPS 
minimal media, pH 7.4.   
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Figure 3.10. Growth of GpdQ+ cells in the presence of organophosphates as the sole 
phosphorus source.  Substrates that were tested included: inorganic phosphate (●), 
diethyl phosphate 9 (●), isoproyl methyl phophonate 11 (●), isobuty methyl phosphonate 
12 (●), mono-ester of soman analog 13 (●), and no phosphate source (●). Substrate 
concentration was 1.0 mM in 1X phosphate free MOPS minimal media, pH 7.4.   
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Effect of Various Phenols on the Growth Rate of E. coli 
 Since the in vivo hydrolysis of organophosphate triesters releases a phenol 
leaving group in the growth culture, E. coli was tested for its growth tolerance to the 
presence of different phenols (Figure 3.11).  Of the three phenols tested, p-nitrophenol 
was the most toxic to E. coli and significantly inhibited its growth.  In contrast,  p-
chlorophenol and p-hydroxyacetophenone displayed a slight inhibitory effect, that could 
possibly be due to the prsence of 1.0% methanol.  Therefore, organophosphate triesters 
with a p-hydroxyacetophenone leaving group are more suitable for in vivo selection 
compared to substrates containing  p-nitrophenol. 
 
Growth of E. coli Co-expressing PTE and GpdQ on Organophosphate Triesters as the 
Sole Phosphorus Source 
 The goal of this experiment was to test the ability of E. coli cells co-expressing 
PTE and GpdQ to grow on the organophosphate triesters, shown in Scheme 5, as the sole 
phosphorus source.   The rate constant kcat/Km for the hydrolysis of 18 (Scheme 3.5) by 
wild type PTE is 2 x 106 M-1s-1.   
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Time course for the hydrolysis of the RVX analog (19) by wild type PTE showed two 
phases with kcat/Km values of 6 x 105 M-1s-1 and 1.3 x 104 M-1s-1 for the fast and slow 
phase, respectively.  GpdQ+ electro-competent cells were transformed with wild type 
PTE and the PTE construct provided by Dr. Tawfik, pET20b-5S.  A graphical 
representation of the growth rate is shown in Figure 3.12.   
 The results from this growth assay are promising.  The length of the lag time for 
E. coli growing under phosphate starvation is dependent on the hydrolysis of the triester 
substrate by PTE.  The 10-fold difference in expression level between the wild type PTE 
and the pET20b-5S construct was very recognizable in the growth assay as the 
GpdQ+/pET20b-5S cells growing on the paraoxon analog (18) experienced a lag time as 
short as 5 hours.  In addition, the 10-fold difference in the kcat/Km values between the 18 
and 19 influenced the bioavailability of the diester in the culture.  GpdQ+/pET20b-5S 
cells growing on the RVX analog exhibited a 2-fold longer lag time than the cells 
utilizing the DE substrate as a phosphate source.   
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Figure 3.11. Time course for the growth of E. coli BL21-DEIII in the presence of 
various phenol leaving groups.  Leaving groups that were tested included: phenol (●), p-
nitrophenol (●), p-chlorophenol (●), and p-hydroxy acetonphenone (●).  As control, cells 
were grown in the absence of any phenols (●) and in the presence of 1% methanol (●).  
Phenol concentration was 1.0 mM.  
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Figure 3.12. Time course for the growth of E. coli co-expressing PTE and GpdQ in the 
presence of organophosphate triesters as the sole phosphorus source.  Strains that were 
tested included: GpdQ+/WT PTE on the paraoxon analog 18 (●), GpdQ+/WT PTE on 
the  RVX analog 19 (●), GpdQ+/pET20b-5S on the paraoxon analog 18 (●), 
GpdQ+/pET20b-5S on the RVX analog 19 (●), and GpdQ+ cell with no substrate (●).  
Substrate concentration was 1.0 mM in 1X phosphate free MOPS minimal  medium, pH 
7.4.    
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 Discussion 
Substrate Specificity of GpdQ 
When applicable, in vivo selection is a powerful tool for identifying interesting 
mutants in a directed evolution experiment.  The use of PTE co-expressed with GpdQ to 
enable E. coli to utilize organophosphate triesters as the sole phosphorus source is 
limited to the substrate promiscuity of the diesterase.  Therefore, the substrate specificity 
of GpdQ was examined using a series of structurally diverse organophosphate diesters 
and phosphonate monoesters.  Consistent with previously published data (Gerlt et al., 
1975, and McLoughlin et al., 2004), GpdQ predominantly exhibits a diesterase activity 
and minimal monoesterase activity.  GpdQ displayed the highest activity towards the 
hydrolysis of bis-pNPP with a kcat/Km value of 6.7 x 103 M-1s-1.  It is not unusual for 
bacterial diesterase to be able to hydrolyze bis-pNPP (Vogel et al., 2002, Shenoy et al., 
2005).  A comparison of the kcat/Km values for p-nitrophenyl phosphates with their 
corresponding p-nitrophenyl phosphonates shows that GpdQ preferentially hydrolyzes 
the phosphate diesters over the phosphonate monoesters. For example, the kcat/Km value 
for the hydrolysis of O-phenyl-p-nitrophenyl phosphate is an order of magnitude higher 
than the kcat/Km for phenyl-p-nitrophenyl phosphonate.  The same trend was observed 
when comparing the kcat/Km values for O-ethyl-p-nitrophenyl phosphate with ethyl-p-
nitrophenyl phosphonate.   
The catalytic efficiency for the hydrolysis of alkyl phosphodiesters and 
phosphonate monoesters is significantly lower compared to the substrates containing the 
p-nitrophenol leaving group.  For example, the kcat/Km for the hydrolysis of diethyl 
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phosphate (DEP) is 5 M-1s-1.  However, it is sufficient to support the growth of E. coli 
under phosphate limiting conditions.  GpdQ is thought to be the first enzyme isolated 
with the ability to hydrolyze alkyl diesters.  A second enzyme that was isolated from 
Delftia acidovorans was shown to enable E. coli to utilize DEP as the sole phosphorus 
source as well (Tehara et al., 2003).  No catalytic parameters for DEP hydrolysis has 
been published for this enzyme yet.  
GpdQ was also able to utilize methyl phosphonate monoesters as substrate to 
support the growth of E. coli under phosphate starvation conditions.  This is the first 
reported activity of GpdQ with this class of compounds.  The highest catalytic efficiency 
obtained (kcat/Km = 33 M-1s-1) was for O-isobutyl methyl phosphonate, which is a 
monoester analog for the nerve agent Russian-VX.  GpdQ did not display any 
measurable activity towards the hydrolysis of the soman analog (13, Scheme 3.2). 
 
Hydrolysis of Methyl-demeton-s and DEVX 
 Initial characterization by Ollis and colleagues indicated that GpdQ hydrolyzes 
methyl-demeton-S with a 10-fold less specific activity than bis-pNPP at pH 8.0 
(McLoughlin et al., 2004).  GpdQ was tested for its ability to hydrolyze the 
phosphotriester thiolates, methyl-demeton-s and DEVX.  The time course for the 
hydrolysis of methyl-demeton-S showed an initial fast phase followed by a slower phase 
with a rate ratio of 10.  The final OD412 indicates that approximately 50% of the 
substrate remains unhydrolyzed.  Similarly, the NMR spectra revealed that 30% of the 
substrate was hydrolyzed after 7.5 hours and the product observed at 4.7 ppm is not 
 121
dimethyl phosphate (DMP).  To determine the identity of the resonance at 4.7 ppm, 10 
mM DMP (chemical shift is 3.0 ppm) was hydrolyzed using 32 μM GpdQ at pH 8.0.  
After an overnight incubation, the DMP was completely hydrolyzed to methyl 
phosphate, which resonates at 4.7 ppm.  Therefore, the product resonance observed in 
the NMR of methyl-demeton-S hydrolysis corresponds to methyl phosphate.  There are 
two possible scenarios for generating methyl phosphate from me-demeton (Scheme 3.6).  
Since no diester intermediate is observed in the current NMR spectra, it is not possible to 
determine if methyl phosphate is generated via route A or B in Scheme 3.6.  
 
 
 
 
 
 
 
Scheme 3.6. Two possible routes for generating the dimethyl phosphate observed in the 
NMR spectra of GpdQ catalyzed hydrolysis of methyl-demeton-S. 
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second order rate constants for the fast and slow phase were calculated as 168 M-1s-1, 
and 25 M-1s-1 respectively, that is slightly higher than the rated obtained for methyl-
demeton-S.   
 
In Vivo Growth Assays           
E. coli BL21-DEIII cells expressing GpdQ were examined for their ability to 
utilize various organophosphate diesters and methyl phosphonate monoesters as a source 
for inorganic phosphate.  As anticipated, the observed growth rate was faster for 
substrates with higher rates of hydrolysis.  For example, cells growing on O-isopropyl 
methyl phosphonate showed a longer lag time than cells growing on DEP or O-isobutyl 
methyl phosphonate.  Similarly, the soman analog 13 did not support the growth of E. 
coli since it is not a substrate for GpdQ.  
The results from the in vivo assays for cells co-expressing GpdQ with PTE 
appear promising.  Two variables were considered: i) the intracellular concentration of 
PTE, and ii) the specific activity of PTE towards the hydrolysis of the substrates tested.  
When GpdQ was co-expressed with PTE, it was clear that a faster growth rate was 
obtained for the faster substrate, paraoxon analog 17.  In the case of pET20b-5S, the 
over-expression of PTE is enhanced approximately 10-fold.  This difference in the 
intracellular concentration of PTE was evident as a significantly shorter lag time for the 
paraoxon analog was observed.   A comparison of the growth rates for GpdQ+/pET20b-
5S cells using the paraoxon analog and the Russian-VX analog 18 suggests that the lag 
phase is clearly dependent on the activity of PTE.  However, as the diesters are 
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produced, the 6-fold difference in kcat/Km for DEP and O-isobutyl methyl phosphonate 
can be noticed in the exponential phase as the cell growing on RVX analog appear to be 
growing slightly faster. 
 
Potential Applications and Future Direction 
 Based on the results obtained from the in vivo growth assays, co-expression of 
PTE and GpdQ appears to be a promising approach for directed evolution of PTE.  
Under the current conditions, the growth rate is limited by PTE activity.  Since the 
stereoselectivity of sarin, soman, VX, and R-VX hydrolysis by PTE is a critical issue for 
efficient detoxification, this approach could be applied for the selection of variants with 
enhanced catalytic efficiency towards the hydrolysis of the most toxic stereoisomer.  The 
employment of in vivo selection for variants with enhanced activity towards the 
hydrolysis of phosphorothiolates is dependent upon further investigations with regard to 
the inhibition of GpdQ during the time course of the reaction.   
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CHAPTER IV 
 
CELLULAR LOCALIZATION OF PHOSPHOTRIESTERASE: 
 
CAN PTE BE TRANSLOCATED TO THE PERIPLASM OF 
 
 ESCHERICHIA COLI ? 
 
Introduction  
 
 Directed evolution strategies have been widely employed to mimic natural 
evolution for developing enzymes with enhanced catalytic efficiency, altered substrate 
specificity, improved thermostability or enantioselectivity.  A combination of ep-PCR 
and saturation mutagenesis was utilized to enhance the enantioselectivity of a bacterial 
lipase from P. aeruginosa (Liebeton et al., 2000).  The best variant contained five amino 
acid substitutions and displayed a 25-fold enhancement in enantioselectivity over the 
wild type enzyme.  Another remarkable example that demonstrated the power of directed 
evolution is the evolution of a glyphosate tolerance gene (Castle et al., 2004).  The 
catalytic efficiency of the enzyme glyphosate N-acetyltransferase (GAT) was improved 
104-fold after eleven rounds of DNA shuffling.  In addition to enhanced activity, the 
evolved GAT displayed higher thermostability compared to the wild type.   
 The success of a directed evolution experiment is dependent on the size of the 
library and the choice of a suitable selection and/or screening approach to identify 
desired variants (Soumillion et al., 2001).  Unlike high throughput screening techniques 
where every clone must be tested, in vivo selection links the survival of a host to the 
desired function.  Therefore, selection is very powerful for isolating interesting variants 
from large size random libraries.  The power of in vivo selection was illustrated by 
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Kagamiyama and co-workers in a study aimed at evolving the E. coli aspartate 
aminotransferase (ApsAT) to a valine aminotransferase (Yano et al., 1998).  Their work 
relied on using the ΔilvE::kan strain for which the gene for branched chain amino acids 
aminotransferase was knocked out.  After five rounds of mutagenesis and selection, they 
isolated an AspAT variant with five orders of magnitude improvement in the catalytic 
efficiency for valine and 2-oxovaline compared to the native enzyme.        
 This chapter aims at the potential use of in vivo selection to identify variants of 
phosphotriesterase with enhanced activity towards the hydrolysis of phosphorothiolates.  
The selection strategy is based on utilizing a substrate that releases cysteine upon 
hydrolysis by PTE (Scheme 4.1).   
 
 
 
 
Scheme 4.1. The hydrolysis of Pcys 1 to liberate cysteine and diethyl phosphate.  
 
A major requirement for this system is an E. coli strain that cannot synthesize cysteine, a 
cysteine auxotroph.  The E. coli cysteine biosynthesis pathway is shown in Scheme 4.2.  
It starts with the acetylation of L-serine to O-acetyl serine by the cycE gene product, 
serine acetyl transferase.  O-acetyl serine is then converted to cysteine by the gene 
products of cysE and cysK.   
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Scheme 4.2. The biosynthesis of cysteine in E. coli K12.  
 
The first reaction in cysteine biosynthesis cannot take place in the E. coli RY1633 strain 
in which the cysE gene has been deleted.  Hence, the survival of RY1633 cells 
expressing PTE will be linked to the hydrolysis of Pcys 1.  One of the in vivo selection 
limitations is the intercellular availability of the substrate of interest.  To overcome this 
constraint, the export of PTE into the periplasmic space of E. coli is discussed.         
      
Materials and Methods 
Materials 
 Restriction enzymes and T4 DNA ligase were purchased from New England 
Biolabs.  Wizard Plus SV miniprep DNA Purification System was obtained from 
Promega.  Flavobacterium sp. was purchased from ATCC (ATCC 27551).  Proteinase K 
and egg white lysozyme were purchased from Sigma-Aldrich.  Pfx platinum DNA 
polymerase was obtained from Invitrogen.  The cysteine leaving group containing VX 
analog (Pcys 1) was synthesized in our laboratory by Dr. YingChung Li.  The medium 
copy number expression vector, pZA32-luc, and the cysteine auxotroph E. coli strain, 
RY1633 (Table 4.1) were generously provided by Dr. Ryland Young, Department of 
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Biochemistry and Biophysics.  DNA sequencing was performed in the GTL, Texas 
A&M University.  Oligonucleotides were obtained from the Integrated DNA 
Technologies (IDT).  Antibodies against PTE were raised in rabbits at the Alpha 
Diagnostic Intl. Inc., San Antonio, TX.  The serum collected was used as the primary 
antibody for all Western blot experiments.   
 
Kinetic Measurements 
All kinetic measurements ware performed on a SPECTRAmax-340 plate reader 
(Molecular Devices Inc, Sunnyvale CA).  Paraoxon hydrolysis was measured by 
monitoring the release of p-nitrophenol (ε400 = 17,000 M-1cm-1) at pH 9.0. The DTNB 
coupling assay was utilized to monitor the hydrolysis of Pcys 1 at pH 8.0.  The reaction 
of glucose-6-phosphate dehydrogenase was used to monitor the spheroplast formation.  
The enzymatic assay contained 3.0 mM glucose-6-phosphate, 2.0 mM NADP+, 3.0 mM 
MgCl2.  The production of NADPH (ε340 = 6.22 mM-1cm-1) was monitored at pH 8.0.  
The kinetic parameters were obtained by fitting the data to equation 1, where v is the 
initial rate, Vmax is the maximal velocity, Km is the Michaelis constant, and [S] is the 
substrate concentration. 
           v = Vmax [S]/Km + [S]                                                            (1) 
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Cloning of the PPTE and the PhoA::PTE Constructs  
 Flavobacterium sp. strain ATCC 27551 was grown in LB medium at 30 °C for 
24 hours. The plasmid containing the opd gene was isolated and used as the template for 
the PCR amplifictaion using pfx platinum DNA polymerase.  The PPTE was cloned 
using the primers, opd-5’-KpnI and opd-3’-AvrII (Table 4.2).  PCR conditions were 95 
°C for 30 seconds, followed by 30 cycles of 95 °C for 1 min, 55 °C for 1 min, 68 °C for 
4 min. and final extension at 68 °C for 10 min.  The 1,100 bp PCR product was purified, 
digested with KpnI and AvrII, and ligated into a similarly digested pZA32-luc. The 
ligation product was transformed in E. coli XL1-blue electro-competent cells for DNA 
sequencing.  The plasmid pJK01 served as a template for constructing the phoA::PTE 
fusion protein using the primers phoA-ss-linker and opd-3’-AvrII (Table 4.2).  
 
Growth Conditions for the Cysteine Selection   
 The E. coli RY1633 cys- strain was transformed with wild type PTE and the 
H254A mutant.  An overnight culture was grown in Luria-Bertani medium containing 
0.05 mg/mL kanamycin at 37 °C and 0.025 mg/mL Chloramphenicol.  Cells were 
washed 3 times with sterile MQ water before inoculation in the minimal medium.  The 
M9 based minimal medium was supplemented with 0.4 % glucose, 0.01 mg/mL 
thymine, 0.05 μg/mL thiamin, 20 μg /mL Pcys 1, 0.05 mg/mL kanamycin, and 0.025 
mg/mL chloramphenicol.  All amino acids, except for cysteine and methionine, were 
added to the minimal medium to a final concentration of 0.02-0.1 mg/mL.  The OD600 
was monitored at 30 °C for 48 hours.  
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Table 4.1. Description of plasmids and strains used in chapter IV. 
Plasmid/Strain Description Reference 
pZA32-Luc A medium copy number, chloramphenicol resistant, 
tac promoter expression vector 
Obtained from  
Dr. Young 
pZA32-opd Wild type PTE cloned in pZA32-luc plasmid 
 
 
pZA32-PPTE Full length PTE cloned from Flavobacterium sp. 
into the pZA32-luc vector 
 
PhoA::PTE Wild type PTE fusion to the phoA signal peptide  
 
 
RY1633 cycE::TN5, cyc-, thy-, thi-, kan r, P1 from CBK 286 Obtained from 
Dr. Young 
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Table 4.2. Sequence of the primers used in chapter IV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer  Sequence (5’-3’) 
opd-5'-KpnI CCC GGC CAC GGT ACC ATG CAA ACG AGA AGG GTT GTG CTC 
opd-3'-AvrII CCG GGT ACC CCT AGG TCA TCA TCA TGA CGC CCG CAA GGT C 
phoA-ss-
linker 
GCC CGC GAC GGT ACC ATG AAA CAA AGC ACT ATT GCA 
CTG GCA CTC TTA CCG TTA CTG TTT ACC CCT GTG ACA AAA 
GCA AGC CTG GCA TCG ATC GGC ACA GGC GAT CGG ATC  
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Spheroplast Formation 
 Spheroplasts from RY1633 cells expressing PTE were formed according to the 
previously published procedure (Broome-Smith et al., 1986).  Cells from a 30 mL 
culture were harvested by centrifugation at 7000 rpm at 4 °C.  Cells were then 
resuspended in 250 μL of 30 mM Tris-HCl, pH 8.0 containing 25% sucrose.  EDTA and 
egg white lysozyme were added to final concentration of 5 mM and 100 μg/mL, 
respectively.  Finally, 250 μL MQ water were added and the cells were incubated at 
room temperature for 3 minutes.  The periplasmic contents were isolated by 
centrifugation at 12,000 x g for 10 minutes.  Cytoplasmic contents were extracted by 
treating the spheroplasts with the Bugbuster reagent.  50 μL spheroplast aliquots were 
incubated with and without proteinase K and incubated at room temperature for 30 
minutes.  The proteinase K digestion was quenched by the addition of PMSF to a final 
concentration of 1 mM.  Cellular fractions were analyzed by SDS-PAGE and western 
blotting.   
      
 Results 
Growth of RY1633 at Different Concentrations of Cysteine  
 The cysteine auxotroph RY1633 strain was tested for its ability to grow on 
different concentrations of cysteine.  Figure 4.1 shows a graphical representation of the 
growth of RY1633 in the presence of 0, 1, 2, 4, 8, and 10 μg/mL cysteine in 1X M9 
minimal medium.  While the optimum concentration of cysteine required to complement 
the auxotroph strain was 8-10 μg/mL, a slow growth rate was observed at concentrations 
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as low as 1 μg/mL cysteine.  In addition, growth of RY1633 in minimal medium 
supplemented with 10 μg/mL was not affected by the presence of 20 μg/mL Pcys 1, 
which indicates that Pcys did not exert any toxicity on E. coli.   
                 
Growth of RY1633 Expressing PTE Utilizing Pcys as a Source of Cysteine 
 To examine the feasibility of the cysteine auxotroph based in vivo selection, the 
kinetic parameters for the hydrolysis of Pcys 1 by wild type PTE and the H254A mutant 
were determined using the DTNB coupling assay (Table 4.3).  Although the turnover 
number is very similar for both proteins, the Km for H254A was 22-fold lower resulting 
in a 30-fold enhancement in kcat/Km over wild type. 
 The RY1633 cells expressing wild type PTE and the H254A mutation were 
tested for their ability to utilize Pcys 1 as a source of cysteine.  The growth curve of the 
cys- strain in minimal medium supplemented with 20 μg/mL Pcys 1 is shown in Figure 
4.2.  As can be seen in Figure 4.2, the cys- cells expressing PTE were able to grow only 
when the medium was supplemented with cysteine, and could not use Pcys 1 to 
complement the cysteine deficiency.  The 30-fold enhancement in catalytic efficiency 
that H254A displayed over wild type did not seem to enhance the growth rate.  This 
observation has raised the question regarding the bioavailability of the substrate, Pcys 1, 
and whether it is able to permeate the cellular membrane to the cytoplasm where PTE is 
expressed. 
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Figure 4.1. Growth curve of the RY1633 cys- strain in 1X M9 based minimal medium.  
The culture was supplemented with; 0 (●), 1.0 (●), 2.0 (●), 4.0 (●), 8.0 (●), and 10.0 (●) 
μg/mL cysteine.  OD600 was monitored at 30 °C for 48 hours.   
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Table 4.3. Kinetic parameters for the hydrolysis of Pcys 1 by wild type PTE and the 
H254A mutant.   
Protein  kcat (s-1) Km (mM) kcat/Km (M-1s-1) 
Wild type 0.1 (0.006) 6.1 (0.9) 16.4 (0.5) 
H254A 0.14 (0.006) 0.27 (0.04) 504 (50) 
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Figure 4.2. Growth of RY1633 expressing PTE in the presence of Pcys as a source of 
cysteine.  Cells were transformed with wild type PTE (●) and the H254A (●) mutant in 
1X M9 minimal medium supplemented with 20 μg/mL Pcys.  As control, cells were 
grown in the absence of cysteine (●) and in the presence of 10 μg/mL cysteine  (●). 
Cells were incubated at 30 °C and growth was monitored by measuring the change in 
OD600.    
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 The native PTE is expressed in Flavobacterium sp. with a leader sequence that 
enables the protein to be translocated to the periplasmic space (Mulbry et al., 1989).  In 
an attempt to express PTE in the periplasm of E. coli, the full length opd gene was 
cloned from Flavobaterium sp. into the expression vector, pZA32-Luc resulting in the 
construct pZA32-PPTE.  The cellular location of PTE was determined by spheroplast 
formation followed by SDS-PAGE fractionation and detection by Western blot.  To 
ensure that no serious spheroplast lysis occurred during the extraction, the activity of the 
cytoplasmic enzyme, glucose-6-phosphate dehydrogenase, was measured using 3.0 mM 
glucose-6-phosphate.  Figure 4.3A shows that wild type PTE expressed in the cytoplasm 
was, in fact, retained in the spheroplast fraction.  The majority of the PPTE protein was 
also present in the spheroplast fraction despite the fact that it was processed to the 
mature length PTE.  A small fraction of PPTE remained in the spheroplast fraction 
without being digested with the signal peptidase.  Table 4.4 shows the total units 
measured for PTE and glucose-6-phosphate dehydrogenase in the periplasmic fraction 
and in the spheroplast.  The cellular location of PTE was verified by testing its 
susceptibility to digestion by proteinase K.  Figure 4.3B shows that neither wild PTE nor 
PPTE was susceptible to proteinase K in the spheroplast.  Purified PTE (2.5 μg) was 
completely digested with 1.0 mg/mL proteinase K after 10 min incubation at room 
temperature (data not shown). 
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Figure 4.3. Cellular fractionation of E. coli expressing the PTE and PPTE constructs. (A) 
Western blot analysis of subcellular fractions of cells expressing PTE and PPTE. 1) 
PPTE spheroplast 2) PPTE periplasmic fraction 3) PPTE total cellular fraction 4) PTE 
spheroplast 5) PTE periplasmic fraction 6) PTE total cellular fraction 7) Purified PTE 8) 
Molecular weight marker. (B) Sensitivity of PTE and PPTE to proteinase K 1) PPTE, no 
proteinase K 2) PPTE 0.2 mg/mL proteinase K 3) PPTE 1.0 mg/mL proteinase K 4) 
PTE, no proteinase K 5) PTE, 0.2 mg/mL proteinase K 6) PTE, 1.0 mg/mL proteinase K 
7) Molecular weight marker 8) Purified PTE. 
A 
B
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Table 4.4. Activity (total units) of PTE and glucose-6-phosphate dehydrogenase in the 
periplasmic fraction and the spheroplast of PTE and PPTE.  The PTE assay contained 
1.0 mM paraoxon and 50 mM CHES buffer, pH 9.0.  The glucose-6-phosphate 
dehydrogenase contained 3.0 mM G-6-P, 2.0 mM NAD+, 3.0 mM MgCl2, and 50 mM 
HEPES buffer, pH 8.0.  
 Wild type PTE Total units (μmol min-1) 
PPTE 
Total units (μmol min-1) 
 
Enzyme   Periplasmic fraction 
Spheroplast 
fraction 
Periplasmic 
fraction 
Sheroplast 
fraction 
 
PTE 0.2 8.5 0.06 3.8 
Glucose-6-phosphate 
dehydrogenase 0.023 3.5 0.01 
3.0 
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Cloning and Expression of the PhoA::PTE Construct 
 Since PTE was not translocated to the periplasm using its native signal peptide, 
the 21 amino acids leader sequence of alkaline phosphatase (PhoA) was utilized in an 
attempt to express PTE in the periplasmic space.  The phoA::PTE construct was 
expressed in RY1633 cells using the pZA32-Luc expression vector.  The first construct 
did not contain a linker between the phoA signal sequence and PTE.  Expression of that 
construct and western blot analysis indicated that the leader sequence of phoA was not 
processed (data not shown).  The second construct contained the ser-leu-ala linker.  It 
was suggested that a short linker is required for recognition by the signal peptidase 
(Dodt et al., 1986).  Cellular fractionation of RY1633 cells expressing the phoA::PTE 
construct indicated that both the full length and the processed forms of PTE remained 
soluble in the spheroplast (Figure 4.4).  The cytoplasmic fraction was concentrated 10-
fold in this experiment.  Table 4.5 shows that most of the PTE activity was in the 
cytoplasmic fraction.   
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Figure 4.4. Cellular localization of wild type PTE and the phoA::PTE construct. Lanes 1 
and 9) Molecular weight marker 2) PhoA::PTE, insoluble fraction 3) phoA::PTE, 
cytoplasmic fraction. 4) PhoA::PTE, periplasmic fraction 5) PTE, insoluble fraction 6) 
PTE, cytoplasmic fraction 7) PTE, periplasmic fraction 8) Purified PTE.   
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Table 4.5. Activity (total units) of PTE and glucose-6-phosphate dehydrogenase in the 
periplasmic, cytoplasmic, and spheroplast fractions of PTE and phoA::PTE.  The PTE 
assay contained 1.0 mM paraoxon and 50 mM CHES buffer, pH 9.0.  The glucose-6-
phosphate dehydrogenase contained 3.0 mM G-6-P, 2.0 mM NAD+, 3.0 mM MgCl2, and 
50 mM HEPES buffer, pH 8.0.  
Enzyme Wild type PTE 
Total units (μmol min-1) 
phoA::PTE 
Total units (μmol min-1) 
 
 Periplasmic 
fraction 
Cytoplasmic 
fraction 
Insoluble 
fraction 
Periplasmic 
fraction 
Cytoplasmic 
fraction 
Insoluble 
Fraction 
 
PTE 
 
0.12 7.0 0.2 0.02 1.8 0.01 
G-6-P 
dehydrogenase 
0.018 3.6 ND 0.04 3.0 ND 
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Discussion: 
In Vivo Selection using the cys- RY1633 Strain 
  In Chapter III of this dissertation, in vivo selection based on a deficiency of a 
vital chemical element, phosphorus, in the growth medium was discussed.  In this 
chapter, a different in vivo selection approach where cysteine is required for the genetic 
complementation of a cys- strain was investigated.  The E. coli K12 strain, RY1633, is 
not capable of synthesizing the amino acid cysteine due to a deletion in the cycE gene.  
Therefore, this strain was used to test the ability of wild type PTE and the H254A mutant 
to complement the cysteine deficiency via hydrolysis of the substrate Pcys 1.  The results 
obtained from the growth experiments showed that the RY1633 cells transformed with 
PTE were able to survive only when the minimal medium was supplement with cysteine.  
Although the catalytic efficiency of H254A is 30-fold higher than the wild type enzyme 
for the hydrolysis of Pcys 1, RY1633 cells expressing H254A were not able to grow in 
the absence of cysteine.   
 In vivo selection based on genetic complementation of an amino acid deficiency 
has been previously described.  Penicillin amidase from E. coli, an enzyme involved in 
the production of semi-synthetic antibiotics, was subjected to random mutagenesis to 
isolate mutants for enhanced hydrolysis of glutaryl-L-leucine, which is not a substrate 
for the wild type enzyme (Forney et al., 1989).  Desired variants were isolated based on 
the growth of a leucine auxotroph E. coli in minimal medium supplemented with 
glutaryl-L-leucine as the sole source of leucine.  More recently, the gene encoding 
glutaryl acylase from Pseudomonas SY-77 was a target for saturation mutagenesis 
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experiments to identify variants with enhanced activity for the hydrolysis of adipyl-7-
ADCA, an intermediate in the semi-synthesis of cephalosporin antibiotics (Sio et al., 
2004).  This system utilized a serine derivative, which upon hydrolysis, liberates serine 
and, therefore, supports the growth of a serine auxotrophic bacterial strain.   
 In both examples, the target enzyme was translocated across the cytoplasmic 
membrane to the periplasmic space of the bacterial host, which enhanced the 
bioavailability of the substrate.  In the case of PTE, the enzyme is expressed in the 
cytoplasm.  Since the Pcys substrate is expected to carry a negative and a positive charge 
at the experimental pH, it is unlikely for the substrate to be able to pass through the 
cellular membrane to the cytoplasm where PTE is located.  Therefore, attention was 
drawn to secretion of PTE into the periplasmic space of E. coli.   
 
Cloning and Expression of Full Length PTE (PPTE) from Flavobaterium sp. 
 Initial characterization of PTE indicated that the protein is expressed with an N-
terminal domain that functions as a signal sequence for protein transport in 
Flavobacterium sp.  Since the deletion of that signal peptide has enhanced the specific 
activity of PTE, the protein has been routinely expressed in the cytoplasm.  For the 
selection purposes, it is preferred to have the target protein secreted into the periplasmic 
space.  Therefore, full length PTE (PPTE) was cloned into the pZA32-luc expression 
vector and expressed in E. coli.  However, cellular fractionation showed that both the 
PPTE and wild type PTE forms were retained soluble in the cytoplasm and were not 
exported.  The paraoxonase activity of both the periplasmic fraction and the spheroplast 
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was in agreement with the majority of PTE retained in the cytoplasm, although the 
activity of the PPTE form was approximately 2-fold less than the wild type PTE.  This is 
consistent with the results obtained from a study conducted in the Wild’s Lab.  Their 
findings indicated that the leader sequence of PTE was able to secrete alkaline 
phosphatase into the periplasm, but it was not successful in exporting PTE (Dave et al., 
1993) 
 
Cloning and Expression of the PhoA::PTE Construct   
 In another attempt to translocate PTE into the periplasm, the 21 amino acid 
signal peptide of the periplasmic protein, alkaline phosphatase (PhoA), was used to 
construct the phoA::PTE fusion.  The fusion protein was expressed in the RY1633 strain 
under the ptac promoter.  Western blot analysis of subcellular fractionation of the 
phoA::PTE fusion indicated that the signal sequence of approximately 50% of the 
protein was digested, while the protein remained soluble in the spheroplast.  The rest of 
the protein was in the full length form and also remained in the spheroplast.   
 Based on the results of this investigation, it was not possible to translocate PTE 
into the periplasmic space using its native signal sequence or the alkaline phosphatase 
signal peptide.  Thus far, the reason for this is not clear.  A possible explanation might 
be that PTE is not recognized by the E. coli SecB and, therefore, the newly synthesized 
polypeptide chain is folded into its native conformation without being exported.  Sec B, 
a component of the E. coli Sec machinery, is an anti-folding molecular chaperone which 
binds to the unfolded protein precursor and delivers it to the SecY/E protein for 
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translocation (Wicker et al., 1991). This limitation can be circumvented by in vivo co-
overexpression of Sec B.  Overexpression of molecular chaperones such as SecB or 
DnaK was successful in enhancing the export of human cytokines into the periplasmic 
space of E. coli (Bergès et al., 1996). 
 Using a different signal peptide could be beneficial in targeting PTE to the 
periplasm.  Cha and co-workers have demonstrated that a fraction of PTE was exported 
to the periplasm of E. coli using the pelB signal sequence (Kang et al., 2006).  Although 
the activity for paraoxon hydrolysis of the pelB::PTE::His6 fusion was 10-fold lower 
than the cytosolic PTE, they showed that approximately 67% of total cellular activity 
was associated with the periplasmic fraction.   
 A more recently characterized export pathway is the Tat pathway (DeLisa et al., 
2002).  Unlike the Sec pathway, the Tat-dependent pathway is specific for partially 
folded or folded proteins.  Proteins translocated via the Tat pathway contain a signal 
peptide with the conserved sequence motif, S/TRRXFLK at the N-region and a 
positively charged amino acid at the C-region of the leader sequence.  The leader peptide 
of PTE contains the signature sequence, MQTRRVVLKS, but it does not contain any 
positively charged residues at the C-region.  To target PTE to the periplasm via the Tat 
pathway, the leader sequence can be slightly modified for better recognition by the Tat 
machinery.         
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
 
Phosphotriesterase has displayed a great potency in hydrolyzing a wide range of 
the extremely toxic organophosphate pesticides and nerve agents.  In addition, PTE is 
the only enzyme known to hydrolyze the V-series nerve agents including VX and 
Russian-VX.  However, the catalytic efficiency for the hydrolysis of phosphorothiolates 
and phosphonothiolates like VX is significantly lower. Chapter II of this dissertation 
aimed at modifying the active site of PTE for enhanced hydrolysis of the VX analogs, 
diisopropyl amiton (DEVX) and demeton-S.  Previous investigations of the substrate 
binding pocket of PTE have demonstrated that the substrate specificity can be altered by 
simultaneously randomizing the residues His245 and His257.  Screening the double 
substitution library H254X/H257X for the hydrolysis of DEVX led to the identification 
of two variants with enhanced activity compared to wild type.  They were identified as 
H254G/H257F and H254Q/H257F.  The double mutant H254Q/H257F displayed a 10-
fold enhancement in kcat and a 3-fold enhancement in kcat/Km over wild type PTE for the 
hydrolysis of DEVX.  When tested for the hydrolysis of demeton-S, H254Q/H257F 
exhibited an 18-fold and a 10-fold improvement in kcat and kcat/Km compared to the wild 
type.   
The substrate binding site of PTE was the target for the first round of random 
mutagenesis.  Twelve single substitution libraries were constructed and screened for the 
hydrolysis of DEVX.  From the H254X library, the mutant H254A showed a 2-fold 
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enhancement over wild type.  The H257S and H257T mutations from the H257X library 
displayed a slight enhancement compared to wild type for the hydrolysis of DEVX.  
From the L303X single substitution library, the L303F mutation was approximately 2-
fold higher than the wild type.  None of the isolated mutations displayed enhancement 
over the H254Q/H257F control.   
 The double mutation H254Q/H257F served as a template for constructing the 
third generation random libraries targeting the active site of PTE.  Most mutations in the 
pZA32-QF/Y309X appeared to be detrimental to DEVX hydrolysis.  The QF/Y309E and 
QF/Y309L were isolated from this library as they displayed similar activity to the QF 
template.  Several variants were isolated from the pZA32-QF/I106X library for 
displaying a comparable activity to the standard QF.  They were identified as QF/I106S, 
QF/I106P, QF/I106Q, and QF/I106L.  The kcat/Km value for QF/I106Q was very similar 
to the QF parent, but the kcat/Km for QF/I106P was 10-fold lower than QF (Table 2.8).  
Similar to the PZA32-QF/Y309X library, the majority of mutations in the pZA32-
QF/L271X were detrimental.  Few mutations did not seem to lower the rate of DEVX 
hydrolysis.  They were identified as L271M, L271V, and L271I.  No improvements for 
the hydrolysis of DEVX resulted from screening the pZA32-QF/F306X and pZA32-
QF/M317X libraries.  All variants isolated were identified as the parent QF except for 
the QF/M317L mutant, which had a similar activity as the standard QF.  From the 
pZA32-QF/S308X library, variants with valine, cysteine, or lysine at position 308 were 
isolated for displaying similar activity to the QF template.  Results from the F132X 
library constructed in the QF template have indicated that the vast majority of the 
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mutations are detrimental to the activity against DEVX.    Only two mutants were 
identified for having beneficial mutations, the QF/F132L and QF/133I mutants.  Thus 
far, H254Q/H257F has the highest improvement for DEVX hydrolysis.   
In chapter III of this dissertation, the feasibility of utilizing the phosphodiesterase 
isolated from E. aerogenes (GpdQ) to enable E. coli to grow on organophosphate 
diesters as the sole phosphorus source was discussed.  The substrate specificity of GpdQ 
was investigated using a small library of organophosphate diesters and phosphonate 
monoesters.  The best substrate tested was bis-p-nitrophenyl phosphate with a kcat/Km 
value of 6.7 x 103 M-1s-1.  Kinetic measurements indicated that GpdQ preferentially 
hydrolyzes p-nitrophenyl phosphates over their corresponding phosphonates.  For 
example, the kcat/Km value for the hydrolysis of O-phenyl-p-nitrophenyl phosphate is 10-
fold higher than the kcat/Km for phenyl-p-nitrophenyl phosphonate.  The catalytic 
efficiency for the hydrolysis of alkyl phosphodiesters and phosphonate monoesters is 
significantly lower compared to the substrates containing the p-nitrophenol leaving 
group.   
Results obtained from the in vivo growth assays indicated that E. coli BL21-
DEIII cells could not survive on organophosphate diesters as a source for inorganic 
phosphate.  However, cells expressing GpdQ were able to utilize organophosphate 
diesters and phosphonate monoesters as the sole phosphorus source with a growth rate 
comparable to the catalytic efficiency.  Based on the findings from the in vivo growth 
assays for E. coli cells co-expressing PTE with GpdQ, it was clear that the growth rate is 
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limited by the intercellular concentration and the catalytic efficiency of PTE rather than 
the activity of the diesterase GpdQ.  
Experiments presented in chapter IV of this dissertation focused on the 
translocation of PTE into the periplasmic space as a tool for the PTE-aided genetic 
complementation of cysteine deficiency in the cysteine auxotroph RY1633.  Protein 
export into the periplasm was proven beneficial for the in vivo selection experiments 
which are based on genetic complementation of an amino acid deficiency (Forney et al., 
1989 and Sio et al., 2002).  The selection scheme is based on the hydrolysis of the Pcys 
substrate, an analog of phosphorothiolates, by PTE to liberate cysteine.  Based on the 
results obtained from the growth assays using wild type PTE and the H254A mutant, it is 
thought that the substrate is not able to cross the inner membrane to the cytoplasm where 
PTE is expressed.  It is generally believed that charged molecules will not pass through 
cell membranes.  Since the cysteine auxotroph RY1633 cells expressing wild type PTE 
and the H254A mutation were not able to utilize the Pcys substrate as a source for 
cysteine, several attempts were made to export PTE to the periplasm.  The full length 
PTE (containing the native leader sequence) was cloned from Flavobacterium sp. and 
expressed in E. coli. Cellular fractionation showed that most of the PTE activity 
remained in the cytoplasm.  Furthermore, expression of PTE with the signal peptide of 
the periplasmic protein alkaline phosphatase did not facilitate the translocation of PTE 
across the inner membrane.  Currently, two more strategies are being considered.  The 
first is to clone PTE with the signal peptide of pelB which is commercially available.  
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The second choice is to modify the leader sequence of PTE to make use of the Tat-
dependent export pathway.    
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